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Systematic Reviews of the Health or Healthcare of People with Intellectual Disabilities:  




Background. Systematic reviews are important in evaluating evidence concerning the health of 
people with intellectual disabilities. This paper conducts a systematic review of systematic reviews to 
identify strengths and gaps in this evidence.   
 
Method.  Electronic literature searches and email requests identified systematic reviews published in 
English from 2008 to 2013 on the health or healthcare of people with intellectual disabilities.  
Reviews were categorised using ICD-10 chapter headings and information extracted regarding 
methods, number of studies reviewed and findings.  
 
Results. Ninety-four reviews were identified.  Fifty-two related to ICD-10 Chapter V: Mental or 
behavioural disorders, 28 to Chapter XXI: Factors influencing health status and contact with services, 
and 14 related to other chapters or encompassed multiple chapters.  Nine reviews were ‘empty’.  No 
reviews were found for many ICD-10 chapter headings. 
 
Conclusions. Systematic reviews are heavily weighted towards mental health, with little coverage of 





People with intellectual disabilities have poorer health than their non-disabled peers, differences in 
health status that are, to a significant extent, avoidable (Emerson and Hatton, 2014, Ouellette-Kuntz, 
2005, NHS Health Scotland, 2004, Krahn et al., 2006, US Department Health & Human Services., 
2002, Van Schrojenstein Lantman-de Valk, 2005, O'Hara et al., 2010).  Responding to these health 
inequalities is a critically important issue for primary and secondary healthcare services (US 
Department of Health & Human Services, 2002, Emerson et al., 2012, Emerson and Hatton, 2014, 
Disability Rights Commission, 2006, Michael, 2008) and demands action on several fronts. This 
includes building a more robust evidence-base of the scale and determinants of health inequalities 
and the effectiveness of interventions to reduce the health inequalities experienced by people with 
intellectual disabilities. For example, existing clinical guidelines relating to areas of health inequality 
for people with intellectual disabilities rarely contain content relevant to people with intellectual 
disabilities (Mizen et al., 2012), an omission at least in part due to under-investment in high quality 
research on the health of people with intellectual disabilities. 
 
Systematic reviews are becoming increasingly important in evaluating evidence concerning the 
health of people with intellectual disabilities. The aim of this paper is to provide an overview of 
systematic reviews published from 2008 to 2013 on the health or healthcare of people with 
intellectual disabilities and to identify gaps and strengths in the coverage of these reviews.  Reviews 
are categorised using Chapter Headings from the International Statistical Classification of Diseases 
and Related Health Problems Tenth Revision (ICD-10) (World Health Organization, 2010) as this is an 
internationally recognised system for classifying health related conditions and has been used 
recently to categorise the main causes of death of people with intellectual disabilities in England 
(Heslop et al., 2013).  The paper aims to identify ICD-10 categories where systematic reviews have 
good coverage and to identify categories where there are currently gaps in the evidence base.  This 
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review also aims to provide information on the extent of the underlying research evidence base on 
topics addressed by identified reviews, by summarising specific aspects of reviews (this information 
is presented via tables).   The paper also aims to compare the ICD-10 categories which have been the 
focus of the reviews identified with those categories which have been found to be important in 
relation to mortality in people with intellectual disabilities to determine the degree of congruence 
between the published evidence base and the major causes of death of people with intellectual 
disabilities. For example, the Confidential Inquiry into Premature Deaths of People with Learning 
Disabilities (CIPOLD) reviewed 247 deaths of people with intellectual disabilities that occurred over a 
two year period in five areas of South West England (Heslop et al., 2013).   Underlying causes and 
immediate causes of death were grouped by ICD-10 categories.  The most common underlying 
causes of death were: heart and circulatory disorders (21%); cancer (20%); nervous system (16%); 
respiratory disorders (15%); congenital and chromosomal (7%); digestive system (5%); external 
causes (4%); endocrine, nutritional and metabolic (3%); and mental and behavioural disorders (2%).    
 
The review has been done to help inform future research on the health or healthcare of people with 
intellectual disabilities.  With limited resources available, it is important that future work is directed 
towards priority areas and that attempts are made to avoid duplication of effort in relation to both 





Electronic literature searches were performed by the first author in July 2013 using the following 
databases: Cochrane Library, Database of Abstracts of Reviews of Effects (DARE), Medline, 
Cumulative Index to Nursing and Allied Health Literature (Cinahl), Embase, PsycINFO, and Web of 
Science.  Searches used word terms (and MeSH/index headings where possible) for ‘intellectual 
disability’ including terms identified in a study using ‘Pearl-Harvesting’ methodology to identify a list 
of search keywords for intellectual disabilities (Sandieson et al., 2010).  These were combined with 
terms for systematic reviews using ‘and’.  Searches were also conducted in specialist intellectual 
disability journals using systematic review terms only.  Search terms are summarised below.  Full 
details of the search strategy can be obtained from the first author.   
 





retard* OR "mental* disab*" OR "mild disab*" OR "moderate* disab*" OR 
"severe* disab*" OR "profound* disab*" OR "multipl* disab*" OR 
"intellectual* disab*" OR "developmental* disab*" OR "substantial* 
disab*" OR "cognitive disab*" OR "mild* handicap*" OR "moderate* 
handicap*" OR "severe* handicap*" OR "mental* handicap*" OR "multi* 
handicap*" OR "profound handicap*" OR "developmental* handicap*" OR 
"developmental* delay*" OR "delay* development" OR "mental* delay*" 
OR "intellectual* delay*" OR "mental* impair*" OR "intellectual* impair*" 




Cochrane/DARE: intellectual disability; mentally disabled persons; 
developmental disabilities.  Cinahl/Medline: mental retardation; intellectual 
disability;  developmental disabilities; mentally disabled persons.  PsycINFO: 




“systematic* review*” OR “meta*analys*” 
 
Searches were designed to identify any systematic reviews relating to people with intellectual 
disabilities and reviews related to health or healthcare selected from these.  This approach was 
taken in preference to attempting to employ specific ‘health’ search terms as this would have 
involved a vast number of search terms.   In addition to database searches, email requests for 
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information on relevant reviews were sent in July 2013 to the International Association for the 
Scientific Study of Intellectual and Developmental Disabilities (IASSIDD) Health Special Interest 
Research Group and the Intellectual Disability Research United Kingdom (UK) Network.  These 
sources identified an initial pool of 205 references.  The full list of 205 references can be obtained 
from the first author.   The following inclusion and exclusion criteria were then applied to the 205 
candidate references by two independent reviewers (the first and second author) based on 
abstracts, or from full text if insufficient information was available in the abstract.  The two 
reviewers discussed any uncertainty regarding inclusion or exclusion of articles until consensus was 
reached.   
 
Inclusion and Exclusion Criteria 
 
The inclusion criteria were:  published in English Language; peer reviewed; publication date (or 
assessed as up to date for Cochrane reviews) from 2008 to 2013; systematic review or review 
adopting rigorous method for identification of literature including multiple search terms and the use 
of more than one electronic literature database; population of interest  people with intellectual 
disabilities; and relates directly to health or health care.  If reviews included people without 
intellectual disabilities, reviews were included if:  results for people with intellectual disabilities were 
presented separately; people with intellectual disabilities constituted 50% or more of the overall 
sample; or the review identified no eligible studies.  As the intention was to provide a broad 
overview of systematic reviews relating to health or healthcare, the exclusion criteria were brief: 
studies focusing on autism or relatively rare conditions associated with intellectual disabilities; and 
studies focusing on measurement instruments related to health.   
 




For those articles meeting the inclusion and exclusion criteria, data were extracted and entered into 
an Excel spreadsheet by the first author in relation to the following: authors, year of publication, 
ICD-10 chapter heading, specific topic (e.g. dementia), focus (e.g. prevalence, pharmacological 
treatment, assessment or diagnosis),  date range covered by searches,  language limits for searches 
(e.g. only covering articles in English language), geographical coverage of included articles, databases 
and other sources used for searches, inclusion and exclusion criteria, quality assessment method, 
review process in relation to independent reviewers, method of analysis, number of studies 
included, total (range and median) number of participants in included studies (calculated using IBM 
SPSS 20 software), main findings, conclusion, and type of review (Cochrane, DARE, or other).   ICD-10 
Chapter Headings were ascertained by entering the main topic of each review into the search facility 
for the ICD-10 Online (see http://apps.who.int/classifications/icd10/browse/2010/en).   
 
Review Process Assessment 
 
The following review process measure was devised based on the Cochrane Handbook definition of 
systematic review and a systematic review quality assessment tool (Shea et al., 2007).  Reviews were 
scored ‘1’ for each of the following giving a possible score range of 0-3:   
1. Searches include one supplementary strategy in addition to electronic searches and 
reference searching (i.e. contact with experts, contact with pharmaceutical companies). 
2. Study selection and/or data extraction performed by two or more independent reviewers.   
3. Assessment of quality of included studies was performed and a quality rating allocated, and 
reported, for each study (i.e. not an overall summary of quality).   
 
The process score does not constitute a thorough assessment of review quality (for example it does 
not account for use of appropriate meta-analysis versus narrative review) but gives an indication in 
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relation to specific elements of the review procedure.   It should be noted that this is based on 
information reported in papers and where information has not been identified in the methodology 
section this is scored as ‘0’ with no attempt being made to clarify processes with review authors. No 
studies were excluded on the basis of these scores, with all exclusions taking place during the initial 
application of the inclusion and exclusion criteria.  Process scores are included in the tabulation of 






Overview of Reviews Identified 
Following application of the inclusion and exclusion criteria by two independent reviewers, a total of 
94 reviews remained of which 19 were Cochrane reviews. Of these, over half (52) related to ICD-10 
Chapter V: Mental and Behavioural Disorders, 28 to Chapter XXI: Factors Influencing Health Status 
and Contact with Services, and 14 related to other chapters or covered multiple chapter headings.    
 
Languages Covered 
The vast majority of reviews were restricted to studies published in the English language.  Reviews 
which specifically mentioned methodologies for the potential inclusion of additional languages 
included the following: translation into English if required (Beavis et al., 2007a, Beavis et al., 2007b); 
inclusion criteria of English abstract but any language full text (Unwin and Deb, 2011, Deb et al., 
2008, Einfeld et al., 2011); searches of Latin American and Caribbean Health Science Literature (LI-
LACS) carried out in Spanish and Portugese, and Scandinavian databases searched using appropriate 
languages (Montgomery et al., 2008, Mayo-Wilson et al., 2008b, Mayo-Wilson et al., 2008a); 
potential inclusion of studies in Dutch and German (Courtenay et al., 2010, de Winter et al., 2011, 
Haveman et al., 2010, Strydom, 2010); Dutch (van de Wouw et al., 2012); Chinese (Chan et al., 2010); 
French (Cleaver et al., 2009); and Portugese, Spanish, French or German (Molina et al., 2011).  
However, it is not possible to comment on the extent to which reviews actually included studies 
published in languages other than English. 
 
Geographical Coverage 
In relation to geographical coverage, over half of the reviews did not present information on the 
countries in which included studies were undertaken.  Where information on countries was given, 
the studies most commonly came from Europe (particularly the UK), North America or Australia.   
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Less commonly, studies were found in high income countries in Asia such as Hong Kong and Japan.  
Only seven reviews clearly identified studies relating to low- or middle-income countries.  A small 
number of reviews identified studies from South Africa (Ali et al., 2012, Einfeld et al., 2011, 
Humphries et al., 2009, Oeseburg et al., 2011).  Other low- and middle-income countries included 
were: India, Pakistan and Vietnam (Ali et al., 2012); China, Mexico and Nigeria (Anders and Davis, 
2010); Chile and China (McGillivray et al., 2013); and Brazil (Willis et al., 2008a). As noted in a review 
of health risks associated with age, there was almost a total lack of information about persons with 
intellectual disability in low- and middle-income countries (Haveman et al., 2010). This lack of 
information on low- and middle-income countries appears to be apparent across almost the entire 
range of reviews on the health or healthcare of people with intellectual disabilities.    
 
‘Empty’ Reviews 
Nine reviews, all of which were Cochrane reviews, found no eligible studies for inclusion.  These are 
summarised in Table 1.  Of these nine ‘empty reviews’, five were concerned with pharmacological 
interventions in relation to mental and behavioural disorders (Duggan and Brylewski, 2004, Mohan 
et al., 2009c, Mohan et al., 2009a, Mohan et al., 2009b, Thomson et al., 2009b).   One was concerned 
with RCTs of both pharmacological and non-pharmacological interventions for sex offenders with 
intellectual disability (Ashman and Duggan, 2008).  Two were related to ICD-10 Chapter XXI: Factors 
influencing health status and contact with health services.  One looked at studies on the 
effectiveness of smart home technologies as an intervention for people with physical disability, 
cognitive impairment or intellectual disability, who are living at home (Martin et al., 2008) and one 
the effectiveness of personal assistance for children and adolescents (age 0 to 18 years) with both 
physical and intellectual impairments (Mayo-Wilson et al., 2008b).  One review was related to 
Chapter VI: Diseases of the nervous system which found one ongoing randomised controlled trial 




Table One Here: 
Summary of reviews identifying no eligible studies (all are Cochrane reviews) 
 
Non-Empty Reviews 
The remaining 85 reviews are summarised in Table 2 (ICD-10 Chapter V: Mental and Behavioural 
Disorders), Table 3 (Chap XXI: Factors influencing health status and contact with health services) and  
Table 4 (Other ICD-10 chapter headings).   These tables present information on authors, date of 
publication, topic, date range covered, inclusion criteria in relation to study designs, number of 
studies included, total number (range and median) of participants in samples (presented separately 
for control groups or comparison groups where these exist), process score, and main findings and 
conclusions (see end of Table 4 for a list of all acronyms used). It is important to note that no 
attempt has been made to critically appraise the reviews with a view to commenting on or altering 
the reported main findings and conclusions.    
 
Due to the high number of reviews identified for Chapter V: Mental and Behavioural Disorders, these 
have been tabulated in three sections in Table 2.  Section I includes reviews relating to 
pharmacological interventions; Section II non-pharmacological interventions; and Section III ‘other’ 
reviews. Similarly, due to the large number of reviews identified for Chapter XXI: Factors influencing 
health status and contact with health services, these have been presented in two broad sections: 
Section I includes reviews relating to health or related services, and Section II reviews related to 
health status or factors influencing health status (see Table 3).  Reviews are listed in each section in 
chronological order from the most recent.     
 
ICD-10 Chapter V: Mental & Behavioural Disorders 
In total, 46 reviews with sufficient data covered topics within ICD-10 Chapter V: Mental & 
Behavioural Disorders: 10 reviews concerning pharmacological interventions (Table 2 Section I), 23 
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reviews concerning non-pharmacological interventions (Table 2 Section II) and 13 reviews 
concerning mixed interventions or other issues related to mental & behavioural disorders (Table 2 
Section III).  
 
Chapter V Mental & Behavioural Disorders Section I: Pharmacological interventions 
Ten reviews were concerned with the efficacy of pharmacological interventions in relation to mental 
and behavioural disorders in people with intellectual disability.  These include three Cochrane 
reviews: pharmacological interventions for self-injurious behaviour (Rana et al., 2013); donepezil for 
Alzheimer’s dementia (AD) in people with Down’s syndrome (Mohan et al., 2009d); and 
amphetamine for attention-deficit hyperactivity disorder (ADHD) (Thomson et al., 2009a).  Other 
reviews considered: atypical antipsychotics for behaviour problems in children with intellectual 
disability or borderline intelligence (Unwin and Deb, 2011); clozapine for behaviour problems (Singh 
et al., 2010); melatonin for sleep problems (Braam et al., 2009); mood stabilizers and antiepileptic 
medication for behaviour problems in adults (Deb et al., 2008); pharmacological treatment of bipolar 
disorder in children and adolescents (Gutkovich and Carlson, 2008); pharmacological management 
of inappropriate sexual behaviours (Sajith et al., 2008); and somatic treatment of psychiatric and 
behavioural problems, including psychotropic medication and electroconvulsive therapy (Ulzen and 
Powers, 2008).  These reviews are summarised in Table 2 Section I.   
 
The majority of these reviews conclude that there is insufficient or poor quality evidence on 
effectiveness on which to base practice, and therefore a need for further trials.  It has been noted 
that prescribing is based on extrapolation from research in people without intellectual disability 
(Thomson et al., 2009a).  The two exceptions to this were: ‘some evidence’ for the use of 
riesperidone to manage behaviour problems in children and adolescents with the caveat that these 
should be used with caution due to possible adverse events (Unwin and Deb, 2011); and results of a 
meta-analysis indicating that melatonin is effective and safe for treating sleep problems with the 
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caveat that long term effects are not known and the drug is non-licensed in most countries (Braam 
et al., 2009).   
Table 2 Section I Here: 
ICD-10 Chapter V Mental and Behavioural Disorders: Pharmacological interventions 
 
Chapter V Mental & Behavioural Disorders Section II: Non-pharmacological interventions 
Twenty three reviews considered non-pharmacological interventions for mental and behavioural 
disorders which are categorised here as psychological, behavioural, or ‘other’ (see Table 2 Section II).  
However, these categories are not entirely mutually exclusive, for example one review notes that 
there is some evidence that psychological interventions can reduce challenging behaviour and that 
they are most effective when linked to functional behaviour analysis (Campbell et al., 2014).  Only 
one Cochrane review was identified in this section and this looked at behavioural and cognitive-
behavioural interventions for aggression (Hassiotis and Hall, 2009). 
 
Eight reviews considered psychological interventions for people with intellectual disability: any 
psychological interventions for challenging behaviour (Campbell et al., 2014); psychologically based 
anger management for adults living in the community (Borsay, 2013); mindfulness training for 
people with intellectual disability or family/paid carers (Chapman et al., 2013); anger management in 
adults (Hamelin et al., 2013); mindfulness for behaviour problems (Harper et al., 2013); mindfulness 
for behavioural or psychological problems (Hwang and Kearney, 2013); cognitive behavioural 
therapy (CBT) for anger (Nicoll et al., 2013); and any psychological therapies (Vereenooghe and 
Langdon, 2013).   
 
The majority of these reviews present some positive study findings for the interventions but overall 
conclusions are limited by methodological weaknesses in the included studies.  However, one review 
and meta-analysis of CBT for anger concludes that the findings indicate at least a medium treatment 
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effect (Nicoll et al., 2013)  and a review and meta-analysis of psychological therapies indicated that it 
was efficacious with a moderate effect size (Vereenooghe and Langdon, 2013).  Finally, one review 
notes that, whilst there is limited research meeting stringent standards of empirical evidence, there 
is some evidence that psychological interventions can reduce challenging behaviour and that they 
are most effective when linked to functional behaviour analysis (Campbell et al., 2014).   
 
Eight reviews consider behavioural interventions.  These reviews tend to be based predominantly on 
single-participant research using designs such as multiple baseline, alternating treatments and 
reversal.  These reviews have looked at: types of motivating operations in interventions for problem 
behaviour with school age children (Simó-Pinatella et al., 2013);  behavioural interventions for 
aggression (Brosnan and Healy, 2011); differential reinforcement to manage problem behaviour in 
adults (Chowdhury and Benson, 2011); behavioural interventions for rumination and operant 
vomiting (Lang et al., 2011); behavioural treatment of chronic skin picking (Lang et al., 2010); non-
contingent reinforcement for problem behaviour (Carr et al., 2009); behavioural treatment of 
elopement (Lang et al., 2009a); and behavioural treatment for self-injurious behaviour (Prangnell, 
2010).   
 
In all but one of these reviews, all or the majority of the studies included reported positive 
improvements following behavioural interventions, with for example 80% of studies reporting 
positive outcomes (Lang et al., 2009a) or improvements in behaviour being reported in all studies 
(Lang et al., 2010) although in some cases, as noted in the latter study, evidence is limited due to a 
paucity of studies.  The one exception was a review on behavioural interventions for self-injurious 
behaviour which found that efficacy was highly variable (Prangnell, 2010).    
 
Finally, there were seven ‘other’ reviews of non-pharmacological interventions, of which one was 
the Cochrane review investigating both behavioural and cognitive-behavioural interventions for 
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aggression (Hassiotis and Hall, 2009).  In addition, reviews considered: the role of engagement in 
meaningful occupation in reducing challenging behaviour (Ball and Fazil, 2013); varied intervention 
programs to treat behavioural problems in children (Petrenko, 2013); effectiveness of augmentative 
and alternative communication (AAC) on challenging behaviour (Walker and Snell, 2013); 
effectiveness of massage therapy on relaxation and challenging behaviour (Chan and Tse, 2011); 
effect of multisensory therapy on challenging, stereotypic and positive behaviour (Chan et al., 2010); 
and effectiveness of multisensory therapy (Snoezelen) in relation to behaviour (Lotan and Gold, 
2009).   
 
For these reviews, whilst some positive outcomes were noted, most of the reviews were 
inconclusive due to a paucity of studies and small numbers of participants, or due to methodological 
weaknesses of the included studies. The one exception is the review of AAC which suggests that 
whilst the quality of studies is somewhat limited, AAC intervention has positive effects in decreasing 
challenging behaviour for people with varying disabilities (predominantly intellectual disability).  
Overall, there is a call for more rigorous research to evaluate these interventions. 
 
Table 2 Section II Here: 
Chapter V Mental & Behavioural Disorders: Non-pharmacological interventions 
 
Chapter V Mental & Behavioural Disorders Section III: Other & Mixed Pharmacological/Non-
pharmacological intervention reviews 
Thirteen reviews either included a mixture of non-pharmacological and pharmacological 
interventions or addressed other issues relevant to mental and behavioural disorders such as 
prevalence (see Table 2 Section III).  Those focussing on varied interventions were: a meta-analysis 
of single-case and small-n research on interventions for reducing challenging behaviour (Heyvaert et 
al., 2012); non-pharmacological (social-psychological) and pharmacological interventions for people 
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with intellectual disability affected by dementia and their carers (Courtenay et al., 2010); a meta-
analysis of biological, psychotherapeutic and contextual interventions for challenging behaviour 
(Heyvaert et al., 2010); and interventions for bruxism (teeth clenching or teeth grinding) (Lang et al., 
2009b). 
 
Other reviews considered interventions within the context of wider scope reviews including 
information on, for example, prevalence.  These included: prevalence, factors associated with and 
treatment of sleep problems in adults (van de Wouw et al., 2012); assessment, prevalence and 
treatment of post-traumatic stress disorder (PTSD) (Mevissen and de Jongh, 2010); and assessment, 
diagnosis and management of personality disorder (Pridding and Procter, 2008). 
 
For reviews considering interventions, some reviews concluded that there was insufficient research 
evidence available relating to interventions including: interventions related to dementia (Courtenay 
et al., 2010); bruxism, although it is noted that some treatments are promising (Lang et al., 2009b); 
and personality disorder (Pridding and Procter, 2008).  Other reviews suggest that there is some 
evidence for interventions although not necessarily based on RCTs.  Case reports suggest positive 
treatment effects for various treatments for PTSD although studies on pharmacological treatments 
are lacking (Mevissen and de Jongh, 2010).   Whilst there is some evidence that interventions 
(mainly based on behavioural or environmental improvement) are beneficial in treating sleep 
problems, research has mainly focused on subjectively derived data (van de Wouw et al., 2012). One 
meta-analysis of various interventions for challenging behaviour found an overall large to medium 
positive effect size with no significant difference for mean effects of biological (most commonly 
atypical antipsychotics), psychotherapeutic and contextual interventions (Heyvaert et al., 2010).  
However, a meta-analysis of single case and small-n research found evidence endorsing the positive 
effects of psychotherapeutic and contextual intervention components, but no evidence for an 




A number of reviews looked at issues related to mental and behavioural disorders without 
consideration of interventions.  These included: the relationship between anxiety and challenging 
behaviour (Pruijssers et al., 2014); the prevalence of psychiatric disorders in adults (Buckles et al., 
2013); determining physical conditions that may be associated with challenging behaviour (de 
Winter et al., 2011); the prevalence of mental disorders in children or adolescents and factors 
associated with prevalence (Einfeld et al., 2011); the clinical presentation of schizophrenia in people 
with mild or borderline intellectual disability compared to those with average or high IQ (Welch et 
al., 2011); and the epidemiology, presentation and diagnosis of dementia (Strydom, 2010). 
 
Table 2 Section III Here: 
Chapter V Mental & Behavioural Disorders: Other & Mixed Pharmacological/Non-pharmacological 
intervention reviews 
 
ICD-10 Chapter XXI; Factors influencing health status or contact with health services 
 
In total, 23 reviews with sufficient data covered topics within ICD-10 Chapter XXI; Factors influencing 
health status or contact with health services: 10 reviews concerning contact with services (Table 3 
Section I) and 16 reviews concerning factors influencing health status (Table 3 Section II).  
 
Chapter XXI Factors Influencing Health Status or Contact with Health Services Section I: Contact with 
Services 
Ten reviews considered contact with health or related services.  Of these, three were Cochrane 
reviews which addressed: organisational interventions aimed at improving the care of mental and 
physical health problems of adults with intellectual disability (Balogh et al., 2008); the effectiveness 
of personal assistance for adults with both physical and intellectual impairments (Mayo-Wilson et 
17 
 
al., 2008a); and the effectiveness of personal assistance for children and adolescents with 
intellectual impairments (Montgomery et al., 2008).  Of the remaining reviews, three considered 
aspects of hospital care: influences on the health, safety and welfare of adults with intellectual 
disabilities in acute hospitals (Bradbury-Jones et al., 2013); factors influencing and interventions 
improving general hospital care (Phillips, 2012); and experiences of secondary healthcare for people 
with intellectual disability (Backer et al., 2009).  Other topics addressed were: ethnic variation in 
uptake of mental health services by people with intellectual disability in high income countries 
(Durà-Vilà and Hodes, 2012); the impact of health checks for people with intellectual disability 
(Robertson et al., 2011); outcomes (including health and related risk factors, mortality,  mental 
health, and behaviour)  in different residential settings for people with intellectual disability (Kozma 
et al., 2009); and evidence relating to informed consent and assessment of mental capacity to 
healthcare interventions for people with intellectual disability (Goldsmith et al., 2008).   
 
With the exception of the Cochrane reviews, which as would be expected focus on RCT-type studies 
of a specific intervention, the reviews in this section cover a wide range of studies including both 
quantitative and qualitative studies.  Even though broad inclusion criteria were used in the reviews, 
only two reviews reported on a substantial number of studies. Firstly, in relation to the international 
evidence on the impact of checking the health of people with intellectual disabilities, 38 studies 
were identified and overall it was concluded that health checks are effective in identifying 
unrecognised health needs, including life threatening conditions (Robertson et al., 2011).  Secondly, 
68 studies were identified relating to outcomes in different residential settings for people with 
intellectual disability and it was concluded that small-scale residential settings are superior to large, 
congregate options in most domains studied (Kozma et al., 2009).   
 
Table 3 Section I Here: 
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Chapter XXI Factors Influencing Health Status and Contact with Health Services: Contact with Health 
Services 
 
Chapter XXI Factors Influencing Health Status and Contact with Services Section II: Factors Influencing 
Health Status 
Sixteen reviews were included in this section (see Table 3 Section II).  Of these, two were Cochrane 
reviews, one looking at the effectiveness of treadmill interventions on locomotor development in 
children and infants under 6 years of age at risk of neuromotor delay (Valentin-Gudiol et al., 2011), 
and one on aerobic exercise training programmes for physiological and psychosocial outcomes in 
adults with Down’s syndrome (Andriolo et al., 2010).  A number of other reviews also considered 
physical therapy or exercise interventions, with specific topics being: effects of exercise training 
interventions on percent body fat (Casey and Rasmussen, 2013); benefits of exercise intervention on 
the fitness of people with Down’s syndrome (Li et al., 2013); meta-analysis of the effects of exercise 
programs (Shin and Park, 2012); effectiveness of physical activity interventions (Bartlo and Klein, 
2011); motivational correlates that contribute to and may be effects of participation in sport, 
recreation, or health-related physical activity (Hutzler and Korsensky, 2010); and the effectiveness of 
treadmill training and body weight support in pediatric rehabilitation including studies based on 
samples of children with Down’s syndrome (Damiano and DeJong, 2009).   
 
These reviews suggest that physical exercise interventions can improve muscular strength and 
balance (Li et al., 2013, Bartlo and Klein, 2011) and may also have some benefit in relation to 
psychosocial outcomes such as self-esteem (Hutzler and Korsensky, 2010) or quality of life  (Bartlo 
and Klein, 2011).  Evidence of an effect in reducing body fat composition is inconclusive (Casey and 
Rasmussen, 2013, Li et al., 2013, Shin and Park, 2012).  Two reviews looking at treadmill training in 
pediatric rehabilitation support its efficacy in promoting independent walking (Valentin-Gudiol et al., 




A number of reviews looked at health promotion interventions more broadly.  Topics addressed 
were: main characteristics of health promotion intervention studies (Naaldenberg et al., 2013); 
feasibility, appropriateness, meaningfulness and effectiveness (FAME) of interventions for tobacco 
or alcohol use in people with mild or moderate intellectual disability (Kerr et al., 2013); evidence for 
physical activity and nutrition health promotion interventions (Heller et al., 2011); and non-surgical 
and non-pharmacological interventions to promote weight loss (Jinks et al., 2011).  Generally, the 
evidence base is reported to be insufficient or lacking rigorous studies, with a call for theoretically 
driven health promotion studies (Naaldenberg et al., 2013, Kerr et al., 2013).   
 
Finally, reviews in this section have covered: incidence and prevalence of mobility limitations in 
adults (Cleaver et al., 2009); nutritional status of adults with intellectual or developmental 
disabilities (Humphries et al., 2009); parental and parenting risk factors associated with obesity in 
children and adolescents (McGillivray et al., 2013); and experiences of and impact of self-stigma in 
people with intellectual disability and courtesy stigma in family carers (Ali et al., 2012).  Overall, 
conclusions were noted to be limited due to a lack of methodological quality of research, although it 
is concluded that significant nutrition related risks exist for adults with intellectual or developmental 
disabilities including poor diet, elevated rates of over- or underweight, significant CVD risk factors 
and multiple limiting secondary conditions (Humphries et al., 2009). 
 
Table 3 Section II Here: 
Chapter XXI Factors influencing health status & contact with health services: Factors Influencing 
Health Status 
 
Other ICD Chapter Heading & Multiple Chapter Heading Topics 
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Finally, 13 reviews were identified in relation either to other ICD-10 Chapters than V or XXI or 
included information relevant to multiple ICD-10 chapters (see Table 4).  These are outlined below 
by ICD-10 chapter. 
 
Chapter II Neoplasms 
Two reviews were found, one looking at cervical cancer risks, frequency and screening (Sullivan et 
al., 2010) and one review, reported across two articles, looking at breast cancer screening and 
awareness (Willis et al., 2008a, Willis et al., 2008b).  In both reviews, although evidence is limited, it 
is concluded that women with intellectual disability should be encouraged to attend screening.   
 
Chapter VI Diseases of the Nervous System 
Two reviews were found.  A Cochrane review on pharmacological interventions for epilepsy broadly 
supports the use of antiepileptic drugs to reduce seizure frequency but was unable to comment of 
the relative efficacy of different medications (Beavis et al., 2007b).  A review on the prevalence, 
reasons and implications of misdiagnosis of epilepsy and improving diagnosis highlighted a lack of 
research and the need to make families and those in services aware of the possibility of misdiagnosis 
(Chapman et al., 2011).  
 
Chaper VII Diseases of the Eye & Adnexa  
One review on the prevalence of ophthalmic abnormalities in children with Down’s syndrome was 
found (Creavin and Brown, 2009).  This review found that conditions that are potentially detrimental 
to vision, such as cataract and glaucoma, are found in a significant minority reinforcing the need for 
early assessment and treatment of people with Down’s syndrome.   
 
Chapter XI Diseases of the Digestive System 
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Three reviews were found.  One looked at preventative and restorative treatment programmes for 
managing dental caries in disabled people (Molina et al., 2011).  This review was unable to produce 
guidance on strategies for the prevention and treatment of dental caries in people with disabilities 
(including intellectual disability) and a call is made for more and higher quality research.  On a 
related topic, one review compared the oral health status of people with intellectual disability to 
those without intellectual disability (Anders and Davis, 2010).  It was concluded that people with 
intellectual disability are more likely to have poor oral hygiene and periodontal disease, and possibly 
more likely to have caries.  Finally, one review looked at the symptoms of gastroesophageal reflux 
disease (GORD) in people with severe intellectual disability (de Veer et al., 2008).  It is concluded 
that no single symptom is clearly related to GORD and carers should be alert to a wide range of 
symptoms. 
 
Chapter XIII: Diseases of the Musculoskeletal System & Connective Tissue 
One review was identified which investigated the prevalence of osteoporosis and osteopenia in 
people with intellectual disability (Srikanth et al., 2011). The majority of studies identified increased 
prevalence of osteoporosis & osteopenia with associated low bone mass density (BMD) and in most 
studies individuals with intellectual disability presented with more than two risk factors (e.g. 
reduced physical activity, increased exposure to antiepileptic or antipsychotic medication).   
 
Chapter XX: External Causes of Morbidity & Mortality  
One review on risk factors and preventive strategies for fall-related injuries was found (Willgoss et 
al., 2010).  Whilst up to 57% of people with intellectual disabilities experienced a fall and falling was 
the cause of 50–62% of all recorded injuries, there was a paucity of evidence for intervention 
strategies identified. 
 
Reviews Covering Multiple Chapter Headings 
22 
 
Three reviews covered topics which spanned multiple ICD-10 chapter headings.  One investigated 
the prevalence of chronic health conditions in children with intellectual disability and found 
prevalence rates to be higher than those reported in studies of children without intellectual 
disability, although the number of studies and conditions covered by these studies were limited 
(Oeseburg et al., 2011).  Two reviews considered age-related morbidity. One looked at age-
associated health risk factors in aging persons with intellectual disability (Haveman et al., 2010).  This 
review found cardiovascular disease (CVD) to be as prevalent and as common a cause of death as in 
the general population, a high occurrence of digestive problems such as GORD, and a growing body 
of research on health risk factors such as overweight and obesity.  Finally, one review covered 
causes of mortality and age-related morbidity in people with Down’s syndrome aged over 40 (Torr et 
al., 2010).  This review concludes that functional decline in older adults with Down’s syndrome 
cannot automatically be assumed to be due to dementia of the Alzheimer type, which is not 
inevitable, as there are very high rates of early onset-age related disorders, especially sensory 
impairments and musculoskeletal disorders.   
Table 4 Here: 
Other ICD Chapter Headings & Multiple Chapter Heading Reviews 
 
Discussion      
The primary aim of this review was to provide an overview of recent systematic reviews on the 
health or healthcare of people with intellectual disabilities and to identify gaps and strengths in the 
coverage of these reviews.  The results indicate that the predominant focus of attention in the 
research literature regarding the health or healthcare of people with intellectual disabilities has 
been mental and behavioural disorders.  There has also been some attention focussed on factors 
influencing health status and contact with health services.  In relation to a number of physical 
conditions, very little or no systematic reviews were identified.  No reviews were identified that 
specifically covered the following ICD-10 Chapters: I Certain infectious diseases and parasitic 
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diseases; III Diseases of the blood and blood forming organs and certain disorders involving the 
immune mechanism; IV Endocrine, nutritional and metabolic diseases (although it could be argued 
that interventions related to body fat could be categorised here instead of under factors influencing 
health status); VIII Diseases of the ear and mastoid process; IX Diseases of the circulatory system; X 
Diseases of the respiratory system; XII diseases of the skin and subcutaneous tissue; XIV Diseases of 
the genitourinary system; XV Pregnancy birth and the puerperium; XVI Certain conditions originating 
in the perinatal period; XVII Congenital malformations, deformations and chromosomal 
abnormalities; XVIII Symptoms, signs and abnormal clinical and laboratory finding not elsewhere 
classified; and XIX Injury, poisoning and certain other consequences of external causes.  
 
The paper also aimed to compare the ICD-10 categories which have been the focus of reviews with 
those found to be important in relation to mortality in people with intellectual disabilities.  The 
balance of topics covered in the reviews does not reflect the most prevalent causes of death for 
people with intellectual disabilities (Glover and Ayub, 2010, Heslop et al., 2013). The most common 
ICD-10 categories for underlying cause of death are poorly covered by existing systematic reviews, if 
at all.  This mismatch between research and causes of death may partly reflect the professional 
dominance of psychiatry and psychology within specialist services for people with intellectual 
disabilities. 
 
This review also aimed to provide an insight into the extent and quality of the underlying research 
evidence base on topics addressed by identified reviews.  Most systematic reviews reported serious 
issues with the methodology of the studies they were reviewing, such that clear conclusions could 
not be drawn.  The review also identified nine ‘empty’ reviews, all of which were Cochrane reviews.  
Generally regarded as the ‘gold standard’ for systematic reviews, Cochrane reviews tend to include 
only RCTs or other robust research designs and when using the stringent criteria for inclusion in 




There are a number of potential reasons for this lack of robust research evidence concerning the 
health and healthcare of people with intellectual disabilities. First, people with intellectual 
disabilities are largely excluded from mainstream health and medical research.  In a study of the 
inclusion of people with intellectual disabilities in medical research trials,  only 6 (2%) of 300 
randomly chosen studies clearly included people with intellectual disabilities (Feldman et al., 2013). 
Over 90% of the studies were designed in ways that would automatically exclude people with 
intellectual disabilities from participating, whereas in at least 70% of the studies people with 
intellectual disabilities could have been included if simple accommodations or procedural 
modifications were made.   
 
Second, there are challenging ethical and logistical problems when conducting RCTs with people 
with intellectual disabilities (Oliver-Africano et al., 2010), for example when considering informed 
consent and when conducting intervention research with a distributed population across multiple 
sites where professional expertise and willingness to engage with people with intellectual disabilities 
is lacking.  
 
Third, administrative datasets within mainstream health services often used for large-scale research 
rarely identify intellectual disability with the reliability and validity required. Similarly, general 
population health surveys rarely include people with intellectual disabilities in sufficient numbers to 
allow meaningful comparisons to be made (Emerson & Hatton, 2014). 
 
Careful prioritisation of both research areas and accompanying research designs is required. For 
many health interventions (for example management of blood pressure or the effectiveness of 
chemotherapy for a particular type of cancer) it is likely that the research evidence for the general 
population will apply equally to people with intellectual disabilities. For these types of question, the 
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research that is likely to be required concerns how these health interventions can be effectively 
delivered to people with intellectual disabilities, in terms of the adjustments required by health 
services to increase the chances of people with intellectual disabilities adhering to medication, diet 
and/or physical activity regimes, for example. Effective identification of people with intellectual 
disabilities within health service datasets will help to identify areas of inequality, and evaluative 
research to investigate the impact of adjustments on the health of people with intellectual 




This review presents a ‘snapshot’ of a specific time period and it may be possible to identify reviews 
on these topics that were published prior to 2008.  There is also an inevitable time lag between 
conducting searches and publishing the results of this review so additional reviews are likely to have 
now been published, and indeed additional examples have been identified (Roy et al., 2014, 
Hellenbach et al., 2014).  Further, there are also ongoing reviews which may address some of these 
gaps in evidence.   A number of relevant Cochrane review protocols were identified:  non-
pharmaceutical management of respiratory morbidity in children with severe global developmental 
delay (Winfield et al., 2013); clozapine for psychotic disorders in adults with intellectual disabilities 
(Paul and Ayub, 2013); and risperidone for disruptive behaviour disorders in children with 
intellectual disabilities (Bezuidenhout et al., 2012).  A series of National Institute for Health Research 
(NIHR) rapid systematic reviews are also being carried out, including reviews on: diabetes in adults 
with intellectual disability; Ischaemic cardiovascular disease including hypercholesterolemia in adults 
with intellectual disability; sexual health in adults with intellectual disability; cancer screening in 
people with intellectual disabilities; and thyroid disorders (Strydom and Buszewicz, 2014).  However, 
initial results suggest that for most conditions data on prevalence and associated factors are 




Further, lack of an existing systematic review does not mean that there is therefore no research on a 
topic and indeed for some topics narrative reviews may exist which did not fulfil the criteria for 
inclusion in this review.  For example, key contextual issues in cancer and intellectual disability have 
been covered in one review which did not meet the inclusion criteria (Hogg and Tuffrey-Wijne, 
2008). Similarly, a report by the IASSIDD Special Interest Group on Aging (Haveman et al., 2009) 
includes information relating to pain and sensory impairment which is not included in the peer 
reviewed article included in this review (Haveman et al., 2010).  A further source of information is a 
book which provides a review of physical and mental health co-morbidities in people with 
intellectual disability using the ICD-10 as a framework (O'Hara et al., 2010).  Each of the 20 chapters 
consist of a review of evidence on ill health with searches including dates up to 2008, including 
topics such as respiratory diseases, obstetric and gynaecological disorders, eye diseases and visual 
impairment, mental illness, and three chapters related to diseases of the nervous system.   
 
The findings of this review also have to be considered in light of two layers of quality.  Firstly, there 
are few high quality studies included within the reviews, with most reviews pointing to a lack of 
credible research on the topic area reviewed.  Secondly the quality of the reviews themselves varies, 
with some falling short of the methodological quality demonstrated by Cochrane reviews and indeed 
some do not purport to be ‘systematic’ reviews.  As such, the findings reported here should be 
considered in relation to the identification of gaps in the research base regarding the health and 
healthcare of people with intellectual disabilities. The findings are not intended as a statement of, 
for example, the established efficacy of specific interventions.  Such conclusions are beyond the 
scope of this paper, although the overall picture presented helps to identify directions and gaps of 




One limitation of the review is that all data were extracted by one reviewer and extraction by two 
independent reviewers would reduce the possibility of error and bias.  Summarising findings from 
reviews, particularly those with a wide scope, necessitates focusing on specific aspects of the 
findings and thus the information presented may represent bias on the part of the reviewer.  
Further, the conclusions and findings are as reported by the authors of the original reviews and 
there has been no attempt to critically appraise these.  What authors consider acceptable evidence 
for the effectiveness of an intervention may differ markedly between reviews.  Finally, it was not 
possible to scrutinise all studies included in reviews when extracting data and there is a possibility of 




The conclusions and recommendations arising from this review fall into two areas: the production of 
systematic reviews; and enhancing the evidence-base on the health and healthcare of people with 
intellectual disabilities.   
 
The production of systematic reviews.  The current imbalance in the topics addressed by reviews has 
led to important gaps and also duplication or near-duplication of effort, with multiple reviews 
addressing similar topics.  Whilst it is important for further systematic reviews to be carried out, 
there is a case for greater co-ordination of efforts in order to redress this imbalance.  There is also a 
lack of consistency in the methodological quality of existing systematic reviews.  International 
identification of priorities for systematic reviews, with larger (and international) teams involved 
would help to increase the quality of reviews, reduce bias and create a clearer programme of work 
on systematic reviews.  The co-ordination of reviews could also consider setting a minimum standard 
for the number and quality of studies that are likely to be included before undertaking them to avoid 




Enhancing the evidence-base.  In many areas, the methodological quality of studies included in the 
reviews is mainly not of sufficient methodological quality or quantity to allow clear conclusions to be 
drawn.  Better targeting of research funding is needed to support research to enhance the 
underlying evidence-base regarding the health and healthcare of people with intellectual disabilities.  
Specifically, there is a need for a greater quantity and quality of research on making reasonable 
adjustments to make health interventions effective for people with intellectual disabilities across 
conditions. Greater clarity is also needed regarding when health research is needed in a topic that is 
specific to people with intellectual disabilities and how people with intellectual disabilities can be 
included and identified within general population health research.   The identification of priorities 
should primarily be guided by general research priorities for intellectual disability. In relation to this, 
the World Health Organisation has addressed setting global research priorities for developmental 
disabilities, including intellectual disabilities and autism (Tomlinson et al., 2014). Finally, from a 
public health perspective, there is a need to increase the volume and quality of research both on the 
health of adults with mild/moderate intellectual disabilities who are unlikely to be identified within 
administrative populations, and on populations of people with intellectual disabilities in low and 
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Table 1: Summary of reviews identifying no eligible studies (all are Cochrane reviews) 
 
Chapter V: Mental & Behavioural Disorders 
Author & Date Topic Dates 
covered 












Inclusion: randomised controlled trials (RCTs); adult males or 
females with ID or borderline ID, either convicted of a sexual offence 
or with sexually offensive behaviour.  Treated within the community, 
hospital or prison.  Interventions to include cognitive behavioural 







people with a 






Inclusion: RCTs, over 18 years of age with both ID & schizophrenia, 
any antipsychotic medication, regardless of dosage, but of one 
month’s duration, compared to placebo of at least one month's 















Inclusion: RCTs (including cross-over studies) of participants with AD 
in DS in which treatment with rivastigmine was administered for more 
than a day & compared with a placebo group; any age, diagnosed 












Inclusion: RCTs (including cross-over studies) of participants with AD 
in DS in which treatment with galantamine was administered for 
more than a day & compared with a placebo group; any age, 












Inclusion: RCTs (including cross-over studies) of participants with AD 
in DS in which treatment with memantine was administered for more 
than a day & compared with a placebo group; any age, diagnosed 
with dementia using standardised instruments.   
Thomson, 
Maltezos, 











All RCTs including cluster randomisation or a cross-over design, both 
published & unpublished, in any language, in which children or adults 
with ADHD & ID were treated with risperidone compared to placebo.  
Exclusion: participants with uncontrolled epilepsy, comorbid 
psychotic illness or a history of head injury. 
Chapter VI Diseases of the nervous system 
Beavis, Kerr, 







people with ID 
1806 to 
2010 
Inclusion: RCTs; Quasi-RCTs with inadequate method of allocation 
concealment; blinded or unblinded; age 12 years & over with 
epilepsy & ID. Non-pharmacological interventions, including: surgical; 
specific diets; psychological interventions; yoga; acupuncture; types 
of relaxation therapy. Seizure related, behavioural, cognitive, quality 
of life (QOL), or adverse effects outcomes.  Exclusion: studies 
specifically recruiting children under 12 years of age;   infantile 
spasms; West syndrome. 
Chapter XXI  Factors influencing health status & contact with health services 
Martin, Kelly, 
Kernohan et al 
(2008) 
Effectiveness 
of smart home 
technologies 





ID, who are 





Inclusion: RCTs, quasi-experimental studies, controlled before & 
after studies (CBAs) & interrupted time series analyses (ITS); adults 
living in their home in a community setting; studies that included 
participants with a physical disability, dementia or ID; interventions - 
social alarms, electronic assistive devices, telecare social alert 
platforms, environmental control systems, automated home 
environments & ’ubiquitous’ homes.   Exclusion: studies solely 

















Inclusion: published or unpublished, RCTs, quasi-RCTs & 
nonrandomised controlled studies of personal assistance compared 
to other forms of support or to ’no-intervention’ (which may include 
unpaid care); children & adolescents (0-18) living in the community 
who require assistance to perform tasks of daily living & to participate 
in normal activities due to permanent physical & intellectual 
impairments; defined personal assistance as individualised support 
for people living in the community by a paid assistant other than a 
healthcare professional for at least 20 hours per week, which is 
provided for an indefinite period of time.   Exclusion: rehabilitation or 
respite care; young people living in institutions; physical impairments 










































5 57 (4-33; 8), 
50 excluding 7 
participants in 
one study who 
did not exhibit 
SIB. Controls: 
n/a all cross 
over design 
1/1/1=3* All studies had a cross-over design. Four trials compared the effects of naltrexone 
versus placebo & one trial compared clomipramine versus placebo.  One of the 
naltrexone versus placebo trials reported that naltrexone had clinically significant effects 
(≥ 33% reduction) on the daily rates of three of the four participants’ most severe form of 
SIB & modest to substantial reductions in SIB for all participants; however, this study did 
not report on statistical significance. Another trial reported that naltrexone attenuated 
SIB in all four participants, with 25 mg & 50 mg doses producing a statistically significant 
decrease in SIB (P value < 0.05). Another trial (eight people) indicated that naltrexone 
administration was associated with significantly fewer days of high frequency self injury 
& significantly more days with low frequency self injury. Naltrexone had different effects 
depending on the form & location of self injury. Another trial with only 26 participants 
found that neither single-dose (100 mg) nor long-term (50 & 150 mg) naltrexone 
treatment had any therapeutic effect on SIB.  Comparison of clomipramine versus 
placebo found no statistically significant benefit for any outcome measure, which 
included SIB rate & intensity, stereotypy & adverse events. However, it showed clinically 
significant improvement in the rate & intensity of SIB & stereotypy.  There were very few 
noteworthy adverse events.  There was insufficient evidence to support the use of drugs 
for participants with SIB, although some of the trials found clinically significant benefits of 
using naltrexone & in one trial, clomipramine, compared with placebo.  No RCTs that 
examined the efficacy of newer & more commonly used medications, for example, 
SSRIs, & newer antipsychotics were found.  Given their widespread use, this is a 

























0/1/1=2 All of the studies found the risperidone group to show a greater degree of positive 
change from baseline compared with the placebo group on all or some of the outcome 
measures.  The most commonly reported adverse events across the studies were 
somnolence, tiredness/drowsiness/fatigue, weight gain (including increased appetite), & 
headache. Five of the studies reported rates of any adverse events. The overall rates of 
any adverse event were common in both risperidone (66.7–100%) & placebo (28.6–
79.5%) treated children but the risperidone group always showed a higher rate of 
adverse events according to the individual studies.  The effectiveness of risperidone 
shown in the double-blind phase was maintained throughout the open label phase for all 
three extension studies. Somnolence, weight gain & headache were commonly reported 


















Main findings & Conclusions 
use of risperidone.  However, because of possible adverse events, these medications 
have to be used with caution. 
Singh, 
Matson, Hill 
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experimental 





0/0/0=0 None of the studies used placebo control, controlled and/or cross-over procedures, 
double blind procedures, standardized dosages & evaluations, & appropriate statistical 
analyses.  Information regarding the social & behavioural effects of clozapine on social & 
behavioural functioning was vague as all of the reviewed studies relied primarily on 
measures of global functioning.  No studies reviewed employed any measure to 
specifically assess the cognitive effects of clozapine.  The most commonly reported side 
effects were sedation & hypersalivation, while other reported side effects included weight 
gain, extrapyramidal symptoms, & tachycardia.  Research on the use of clozapine to 
manage behaviour among individuals with ID is inconclusive at best. Based on the 
quantity & quality of the available research, it was not possible to draw any definitive 
conclusions about Clozapine’s cognitive or behavioural effects among this population. 
Braam, 
Smits, 















183 (6-51; 9) 
including 
controls (ns 




0/1/1=2 Melatonin decreased sleep latency by a mean of 34 minutes (p<0.001), significantly 
decreased mean number of wakes per night (p=0.024), & increased total sleep time by 
50 minutes (p<0.001).  Reports on adverse effects were given in four studies. Adverse 
effects were minor & their incidence in both melatonin & placebo phases were the same. 
Results of meta-analysis indicated that melatonin was effective & safe in the treatment of 
sleep problems in individuals with ID, at least in short-term treatment. Although 
melatonin can be prescribed safely in individuals with sleep problems & ID, prescribers 
should realize that melatonin is a non-licensed drug in most countries, & that its long 



















1 30 in one 




1/1/1=3* One small RCT on the effect of donepezil was found. No significant differences were 
found on any four validated outcomes including global functioning & three measures of 
cognitive abilities & behavioural problems. 6 out of 16 carers (37%) of participants on 
donepezil & 2 out of 15 (13%) on placebo reported improvement. No data were available 
for day to day skills, institutionalisation, reduction in carers’ stress or economic 
outcomes. Half the intervention group & 20% of the placebo group reported adverse 
events; 2 participants left because of adverse events.  The one study shows, at best, a 
modest, non statistically significant trend in favour of people with DS & AD who are able 
to tolerate donepezil (this drug is currently only dispensed in relatively large doses & is 
contraindicated for those with cardiac & respiratory problems).This study does not 
provide good evidence on which to base practice. Findings in an open-label follow up to 
this study suggest possible benefit in some individuals. Further, larger RCTs with longer-
term follow up are required. 


















Main findings & Conclusions 
Maltezos, 
Paliokosta 












each of treatment with amfetamine, methylphenidate, & placebo.  The one included 
study only presented graphs of results.  Although positive trends were identified, no 
significant differences (using t-tests) were reported between amfetamine & placebo for 
any measures of ADHD symptoms.  Ten out of 15 participants (all 15 children with 
Fragile X/ID/ADHD) were considered clinical responders to either methylphenidate or 
amfetamine, according to teacher & parent reports.  The number who responded to 
amfetamine is not reported, though two participants were continued on amfetamine after 
the end of the study.  Mean side effects scores were significantly higher for amfetamine 
compared to placebo (28.5 & 17.5 respectively; p=0.05). The most frequent complaints 
were mood lability & irritability. There was very little evidence for the effectiveness of 
amfetamine for ADHD in people with ID. Prescribing in this population is based on 
extrapolation of research in people without ID. More research into effectiveness & 











adults with ID 
Pre-1990 
to 2006 
All types of 
trials 
including 
RCTs & case 
series 
7 228 (10-66; 
28).  Controls: 




1/1/1=3 One RCT relating to lithium & two non-RCTs, one on lithium & the other on 
carbamazepine, were identified. One prospective noncontrolled trial on sodium valproate 
& three retrospective case series studies were identified, of which one considered the 
efficacy of lithium, one valproate & one topiramate.  Between 40% & 74% of participants 
in the reviewed studies were noted to have 'improved' (although it should be noted that 
in the former study 40% also 'improved' in a placebo condition, & one further study 
reported 30% 'improved' in placebo).  Evidence lends some support for the use of lithium 
& some antiepileptic mood stabilizer medication for the management of behaviour 
problems in adults with ID but findings should be interpreted with caution due to 
methodological limitations of the studies reviewed.  More methodologically sound trials 


















series & case 
reports 
included. 
17 40 (1-18; 1).  
Controls: n/a 
mainly case 
series or case 
reports  or ns 
separately 
0/0/0=0 Lithium: total 18 participants in case/case series, including 14 with ID.  Carbamazepine:  
total 2 cases both with ID;  lithium carbonate valporate: total 8 case/case series, 5 with 
ID.  Valproic acid: 2 open label trials, total 28, of which 19 with ID. Largely anecdotal 
accounts showed some effectiveness of mood-stabilizing agents & atypical 
antipsychotics in people with all degrees of ID including profound ID.  Weakness of the 
data prohibits definitive conclusions.  Clinical trials are needed to accumulate data for 





















1/0/0=1 5 studies of cyproterone acetate (CPA) were identified that included participants with ID, 
3 of medroxyprogesterone acetate (MPA), & 3 of luteinising hormone releasing hormone 
(LHRH) agonists.    CPA trials were conducted in 1970s & suffered from poor 




























groups noted  
For MPA, 3 case reports were identified, with all 3 patients showing marked 
improvement in their ISBs but relapse on discontinuation or reduction in dose of MPA.  
For LHRH agonists,  2 uncontrolled trials & 1 case report with numbers of people with ID 
included  ranging 1 to 3 were identified; remarkable improvement in ISBs were noted 
which were maintained over many years while on treatment but two patients relapsed on 
discontinuation of treatment.  The quality of evidence base for the use of 
pharmacological agents in the treatment of ISBs was inadequate to justify their use in 
routine clinical practice. If used, they should only be a part of a comprehensive treatment 











therapy (ECT))  















ns ns 0/0/0=0 The review revealed few RCTs on the medications frequently prescribed for patients with 
ID. Three RCTs of risperidone in children, one combining adults & children, & one with 
adults only are discussed. There was one RCT involving quetiapine & one on citalopram.  
The few RCTs involving the use of risperidone in managing aggression showed some 
promise but were limited by numerous methodological issues including very small 
sample sizes which reduced the power of the statistical analyses. Other than the few 
studies involving risperidone, the overall quality of studies was poor. There was little 
evidence to support the scope of psychotropic medication use in the ID population.  The 
contribution of psychiatric illness to challenging behaviours was not systematically 










































194 (1-63; 15) 
includes 







1/1/1=3 Of the 20 papers, eight were at level of evidence ‘A’; four at level ‘B’; & eight at evidence 
level ‘C’.  The findings & recommendations from papers included offer some evidence 
that psychological interventions can effectively reduce CB. Interventions were most 
effective when linked to functional behaviour analysis.  Constructional approaches were 
also effective; specialist behaviour therapy teams were more clinically effective than 
standard multi-disciplinary teams working alone; & active support training for staff 
worked well with people who present the most difficult CB. There was a limited amount 
of efficacy research that met the most stringent standards of empirical evidence.  There 
was no one intervention or combination of interventions associated with highly effective 
results for all categories of behaviour.  Consideration is needed of who the interventions 
work for, when, where & how. 















1/0/1=2 Authors note it is very hard to draw definitive conclusions from this review due to the 
limited number & variable quality of the research identified.  There is a suggestion that 
when a well organised, skilled approach is taken to engage people in activity, it may be 
effective in reducing CB, although this was not supported in all the literature. The limited 
evidence identified in this review suggests that there is a need for further, more robust 








adults with ID 


















& 88 wait list 
controls 
0/0/0=0 The majority of studies (11) adopted a Cognitive Behavioural Therapy (CBT) approach to 
intervention; 10 of these made use of a group format. Evidence for the effectiveness of 
CBT interventions for anger management in adults with ID was mixed. The majority of 
studies showed evidence of statistically significant improvement on questionnaire 
measures for active vs. control participants, & gains were typically maintained at follow-
up periods of up to 12 months. However, clinically significant change, where calculated, 
was seen in less than a third of participants.  Two studies (one single case, one case 
series) with a total of 4 participants used a mindfulness-based approach to anger 
management.  One case study discussed the impact of individual psychodynamic 
psychotherapy.  Methodological weaknesses made it difficult to draw any firm 
conclusions about the effectiveness of the different approaches.  There are examples in 
the literature of people who have benefitted from CBT, mindfulness & psychodynamic 
psychotherapy approaches. However, there are also examples of people who do not 
appear to have shown sufficient improvement, particularly when the more stringent 
calculation of clinical change is applied. 
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or family/paid 
carers 







3).  Family 
carers: n=4 & 
n=3.  Paid 





practice (EBP).  The studies found improvements in aggression & sexual arousal for 
people with ID after mindfulness training. Training staff led to benefits for people with ID, 
decreased use of physical restraint for aggressive behaviour & increased job 
satisfaction. Training parents led to improved parental satisfaction & well-being & 
improved parent–child interactions. Serious methodological limitations mean that the 
positive findings should be treated with caution, & it is debateable whether the evidence 




















8 192 (7-50; 
18).  Controls: 
144 (7-34; 
17.5) 
0/0/0=0 Two RCTs & 6 pretest-posttest nonequivalent control group studies identified.  The 
unweighted mean Cohen’s d for the between-group effect size of RCT studies was 1.52 
(range 1.49–1.54) & would be considered large. The unweighted mean Cohen’s d for the 
between-group effect size of pretest posttest nonequivalent control group studies was 
0.89 (range 0.16–1.32). One study also found a large effect size (d = 1.21) for an anger 
intervention that was administered individually rather than in a group. Tabulation of 
studies indicates that most effect sizes were medium to large.  Methodological limitations 
mean it was not possible to conclude that anger management is effective (e.g. all studies 
used a wait-list comparison group which may introduce confounds, no studies 
demonstrated treatment integrity, all studies used self & staff reports of behaviour but did 
not validate these reports against actual behaviour). Given these extensive 
methodological limitations, it cannot be concluded that anger management is an EBP 










people with ID 









0/0/0=1 Eleven studies used multiple baseline designs, 7 used pre-post designs, 5 were single 
case studies.  No RCTs.  Consistently positive outcomes were reported across all 18 
studies e.g. all 10 studies that recorded aggression as the dependent variable found a 
reduction in aggression. Other studies found positive outcomes including reduced: 
stress, obsessive thoughts, self injury, injury to staff, depression & anxiety, & staff use of 
medication & restraints.   More rigorous research with improved designs & greater 



















12; 9 with ID 
sample 
22 (1-6; 3) in 




0/0/0=0 9 studies had ID sample, 7 of which used 'meditation on soles of feet' as all or part of the 
intervention where attention directed to a neutral part of the body.  All except one study 
(which used a pre-post no-control group design) employed a single subject design 
(seven multiple-subject & four single-subject studies). Of these, 10 studies, conducted 
by the same research group, adopted a multiple baseline design.     All studies reported 
positive effects for individuals with DD from mindfulness practice.  In seven studies 



















disabilities (DD) disorder (ASD), aggressive behaviour decreased to zero or near zero. Single subject 
studies with people with ID demonstrated weight loss, smoking cessation, & reduction of 
anxiety.  The use of mindfulness to control deviant sexual arousal in one study of 
offenders with ID appeared less clinically successful than its use to reduce aggressive 
behaviour, where reported levels of sexual arousal reduced from 12 (a maximum level) 
for all three participants to 2.95, 3.03 & 1.51.  Despite methodological problems including 
absence of both a clear definition of mindfulness & assessment of intervention fidelity, 
the intervention studies demonstrated the possible usefulness of mindfulness for 





CBT for anger 













237 (5-50; 14) 
may include 




81 (9-36; 18) 
0/1/1=2 The meta-analysis yielded an overall uncontrolled effect size of 0.88 (95% CI = 0.65–
1.12, N = 168).  Analysis of group treatment alone yielded an uncontrolled effect size of 
0.84 (95% CI = 0.57–1.12, N = 123), & analysis of individual treatment formats yielded 
an uncontrolled effect size of 1.01 (95% CI = 0.54–1.48, N = 45). These are considered 
to be large effect sizes.  However, confidence intervals were wide, & the anger literature 
was restricted by the small study sample sizes.  It was advised that the effect sizes 
should be interpreted cautiously & that particular attention be given to the lower ranges 
of the effect sizes reported.  Despite these issues & limitations, the findings indicate at 



















251 in 3 ID 





0/0/0=0 Three studies focused on interventions specifically for children with ID.  One RCT of 
parent child interaction therapy found a reduction in behaviour problems; a quasi-
experimental controlled trial found no difference in child behaviour for a ‘Signposts for 
Building Better Behaviour Programme’; and a quasi-experimental controlled trial of a 
multi-component intervention found improved parent reported severity of behaviour but 
no change in frequency.  Results from studies targeting children with ID were more 
varied than those in the review generally  due to wide differences in the nature of the 
samples (e.g., severity of ID, whether excluded autism), length of intervention, mode of 

























0/1/0=1 All of the designs evaluated were for single-participant research. The designs most 
frequently used were reversal design (n = 17), multielement (n = 16),  multiple baseline 
(n = 3), alternating treatments (n = 3), & multiprobe design (n = 2). Nine studies used 
more than one design.  Across participants, problem behaviour was maintained by 
automatic reinforcement (n = 19, 34.54%), escape (n = 12, 21.81%), attention (n = 9, 
16.36%), & tangible reinforcement (n = 6,  0.9%). Problem behaviour was maintained by 
multiple functions for six participants (10.9%), & the behavioural function was not 
specified for three participants (5.45%).  The studies included many different MOs.  Most 



















environment MOs. A small number of interventions took place involving a MO of the 
participant’s personal context, & very few interventions considered the activity or nature 
of the task.  The majority of the MOs had a clear effect (establishing or abolishing) on 
the problem behaviour in the predicted direction.  The review suggests that antecedent 
interventions involving MOs have a clear effect on problem behaviour. That is, when an 
antecedent event that serves as a MO is changed or modified, the problem behaviour 








people with ID 
ns to 2012 Intervention 
studies with 
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independent 
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20).  Controls 
(where 
stated): 81 (9-
36; 18).   
0/0/1=1 The results of the meta-analysis indicated that psychological therapy with people who 
have ID is efficacious with a moderate effect size of g = .682 when calculated using all 
the studies included within the current review. However, this effect size varied depending 
on whether the studies made use of randomisation, individual or group based 
interventions, & also varied according to the type of problem being treated. Studies 
evaluating CBT for depression generated a moderate to large effect size, g = .742  (95% 
CI =.116-1.599, N = 126).  CBT for anger & aggression had an average estimated effect 
size of g = .827 (95% CI =.508- 1.146, N = 494).  Randomised studies were associated 
with a lower, but moderate effect size, g = .555, compared to non-randomised studies 
which had a large effect size, g = .846. Individual therapy, g = .778, appeared superior to 
group-based interventions, g = .558; & there was no evidence that therapy had an effect 
on interpersonal functioning, g = .342.  Psychological therapy has a moderate effect in 
treating symptoms of mental health problems amongst people with IDs. The results 
further suggest CBT to be at least moderately effective in the treatment of anger & 
depression. Individual therapy may be more effective than group psychotherapy, but this 







(AAC) on CB in 
people with 
disabilities 





111 (1-8; 2); 
of these 75% 
ID. Controls: 
n/a single 
case designs  
0/1/1=2 Meta-analysis with effect size calculated using Nonoverlap of All Pairs (NAP).The mean 
effect size across all participants was .88 (moderate).  For those with ID (n=83) NAP 
effect size was .87 (moderate).    Across all participants, one participant characteristic & 
two intervention characteristics were found to moderate intervention effects.  Age: effect 
sizes were weaker for those aged 18+ (.74) than for those aged 5 or less (.86) or 5 to 12 
(.89).  There were stronger effects for those who received functional communication 
training (FCT) intervention (.87) than those who received picture exchange 
communication system (PECS) intervention (.74).  There were stronger effects for 
interventions that applied a functional behaviour assessment (FBA) to determine the 
function of behaviour (.88) than for interventions that did not (.72).  AAC intervention has 
positive effects in decreasing CB for individuals with varying disabilities (predominantly 
ID).  AAC intervention may be more effective for younger persons, where a FBA is 


































18 30 (1-4; 1); at 
least 15 of 
whom had ID 




0/0/0=0 The designs most utilized were: multiple baseline (6); multi-element (6); reversal design 
(4); alternating treatments design (1); ABCD design (1).  Of the interventions employed 
the most common were extinction (7), & functional communication training (5). A number 
of studies incorporated visual cue prompts (5), differential reinforcement procedures (5); 
& environmental enrichment (3).  All studies reported decreases in CB attributed to the 
intervention. Seven reported total or near elimination of aggression of at least one 
individual during intervention in at least one condition.  Overall, the single subject design 
studies reviewed suggest that the treatments implemented have effectively decreased or 
eliminated aggression in individuals with developmental disabilities (ASD, ID & ASD & 
ID) aged 3–18 years. 












7; 2 of these 
based on 
same 
sample of 8 
20 (1-8; 3); 






0/0/0=0 Five studies used a case study design & two used cross-over designs, no study 
employed an experimental design or RCT.  All studies used behaviour observations as 
part of their outcome measures.  Subjects with severe CB showed a decreased 
frequency of such behaviours after the interventions in 4 studies.  Based on narrative 
data from caregivers & behaviour observations, positive behaviours generally increased 
following massage therapy. The effectiveness of massage therapy is inconclusive 
because of the paucity of studies & the small number of participants.  More rigorous 
research designs, e.g. experimental or randomized clinical trials, are needed to evaluate 



















31; 22 with 
sample size 
of 1 




0/0/1=1 15 studies reported DR to be an effective intervention when used independently. Of the 
remaining, 10 studies found DR to be useful as part of a treatment package, & six found 
a DR contingency used independently to be ineffective, & only observed treatment 
effects when an aversive component was added.  Very few studies assessed the use of 
DR in older adults & in individuals with mild ID. The overall positive findings about the 
effectiveness of DR were considered encouraging but more methodologically robust 



















21 32 (1-5; 1);  
29 with severe 
or profound 
ID.  Controls: 
n/a single 
case designs 
0/1/1=2 Intervention outcomes were summarized by calculating the Nonoverlap of All Pairs 
(NAP).  NAP scores between 0 & 65% can be classified as ‘‘weak effects’’, 66–92% as 
‘‘medium effects’’, & 92–100% as ‘‘strong effects’. Found 3 general approaches to 
intervention: (a) diet manipulations that involved either increasing the amount of food or 
calories consumed or withholding certain foods or liquids (across these studies the mean 
NAP was 90.9%); (b) sensory-based interventions in which the participant was either 
provided with an alternative means to obtain automatic reinforcement or access to the 



















socially mediated reinforcers in which the participants’ access to attention from staff or 
escape from demands was manipulated (mean NAP 86.3%). Combined, the results 
suggest that behavioural interventions for rumination & operant vomiting can produce 
sustained positive effects across time and settings. However, although reductions in 
rumination & operant vomiting were reported in all 21 of the included studies, caution is 
warranted in the interpretation of these results. Specifically, only three of the included 
studies could be classified as providing a conclusive level of certainty.  A comparison of 
the studies included in this current review to the studies included in previous reviews 
reveals a shift away from punishment & towards function-based interventions & diet 
manipulations.  Preliminary guidelines for practitioners faced with assessing & treating 
these behaviours are offered & directions for future research are discussed. 
Chan, 
Thompson, 
Chau et al 
(2010) 


















17 304 (1-96; 8).  
Controls: 3 
studies n=1, 
30 & 41  
0/1/1=2 Developmental disability defined as ‘Mental retardation’ as in DSM-IV in this review. All 
studies adopted a repeated measures design. Thirteen studies had a single treatment 
group but some adopted cross-over design or reversal design with two or more 
treatments.  One had two comparison groups, i.e. experimental & controlled. One also 
had two comparison groups & adopted a cross-over design. One had three groups using 
a counterbalanced design. One had three comparison groups; control, placebo-control & 
treatment.  The evidence suggests that participants displayed more positive behaviour 
after multisensory therapy sessions. Lack of trial-derived evidence makes it difficult to 
arrive at a conclusion on the effectiveness of the multisensory therapy & there is 
insufficient evidence for multisensory therapy as a way to reduce challenging or 
stereotypic behaviour. Future study should use well-designed RCTs to evaluate the short 
















16 19 (1-2; 1); of 
these 13 ID & 
2 borderline 
ID.  Controls: 
n/a single 
case designs 
0/1/1=2 Main findings were summarized for the single-case experimental designs by calculating 
the percentage of non-overlapping data (PND). Treatment approaches included 
combinations of differential reinforcement, providing preferred items & activities stimuli 
(e.g., toys), wearing protective clothing (e.g., helmets or gloves), response interruption & 
redirection, punishment, & extinction. In terms of reducing skin-picking, outcomes across 
studies were judged to be positive. The mean PND across studies was 97% (range, 75–
100%) although PND could not be calculated for one study due to a zero quantity in 
baseline.  Nine studies collected maintenance data & demonstrated persistent treatment 
effects following intervention from 2 to 35 months.  Improvements in behaviour were 
reported in all of the reviewed studies.  However, none of the reviewed treatments would 
qualify as ‘’well established’.  The evidence is limited because of the sheer paucity of 
studies & the small number of participants.    




































NCR of whom 
81.6% 
diagnosed 
with ID.  
Controls: n/a 
single case 
designs   
successfully treated with at least one of the NCR treatments. The other nine participants 
(15.5%) who engaged in problem behaviour were treated with a treatment other than 
NCR.  The most commonly treated topographies of problem behaviour were SIB (55.1% 
of participants) & aggression (51.0%), followed by disruptive behaviour (20.4%), property 
destruction (10.2%), & inappropriate vocalizations (6.2%).  Analysis of efficacy 
conducted using 24 studies of appropriate quality.  Two measures of effect size 
calculated, percentage of non-overlapping data (PND) & mean baseline reduction 
(MBLR). The fixed time + extinction with schedule thinning (FTST + EXT) treatment was 
deemed well established, with 11 studies demonstrating its efficacy with 25 participants. 
The mean PND & MBLR values for FTST + EXT treatments were 70.7 (S.D. = 38.1) & 
85.1 (S.D. = 16.2), respectively. No studies were identified that employed variable time + 
extinction with schedule thinning (VTST + EXT) treatments although it is noted to be 
similar to FTST + EXT treatment.  The fixed time + extinction (FT + EXT) treatment was 
deemed probably efficacious, with 8 studies demonstrating its efficacy with 15 
participants.  The mean PND & MBLR values for FT + EXT treatments were 66.7 (S.D. = 
39.3) & 78.6 (S.D. = 20.9), respectively.  The variable time + extinction (VT + EXT) 
treatment was deemed probably efficacious, with three studies demonstrating its efficacy 
with seven participants. The mean PND & MBLR values for VT + EXT treatments were 
80.9 (S.D. = 35.8) & 81.5 (S.D. = 14.8), respectively. The fixed time (FT) treatment was 
classified as experimental because only two supporting studies were identified in which 
FT was implemented for five participants. The mean PND & MBLR values for FT 
treatments were 83.7 (S.D. = 32.4) & 82.3 (S.D. = 25.3), respectively.  Fixed-time 
reinforcer delivery (plus extinction & schedule thinning) was classified as well 
established, while fixed time reinforcer delivery (plus extinction) & variable-time 




















4 50 (6-18; 13).  
Controls: 44 
(6-20; 9) 
1/1/1=3* Only four heterogeneous small studies identified so the results should be treated with 
caution.  Direct interventions based on cognitive-behavioural methods (modified 
relaxation, assertiveness training with problem solving, & anger management) appear to 
have some impact on reduction of aggressive behaviour at the end of treatment & in 
some studies also at follow up (up to six months). Caregiver & individual ratings post 
treatment (assertiveness, problem solving interventions & CBT) showed improvement in 
measures of emotional distress, anger management & adaptive functioning compared 
with the control group in all but one study.  There is some evidence that behavioural & 
cognitive behavioural treatments are efficacious on their own in the long term 
management of outwardly-directed aggression. All four of the included studies report 



















intervals given are quite wide. There is a paucity of methodologically sound clinical trials. 
RCTs of sufficient power, using primary outcomes of reduction in outward directed 
aggression, improvement in quality of life & cost efficacy as measured by standardised 




et al (2009) 
Treatment of 
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10 53 (1-39; 1); 




0/1/1=2 Combinations of the following intervention components were utilised: (a) differential 
reinforcement, (b) extinction, (c) time out procedure, (d) token economy, (e) response 
cost, (f) functional communication training, (g) response blocking, & (h) non-contingent 
reinforcement. One study evaluated a single component intervention (scheduled periods 
of exercise).  Overall, 80% of the studies reported positive outcomes & 20% reported 
mixed outcomes. The evidence base suggests that function-based assessment (e.g. 
functional analysis procedures) & function-based treatments (e.g. functional 
communication training) may be most effective in the treatment of elopement in this 
population.  However, evidence must be considered limited because of the sheer paucity 
of studies & the relatively few number of participants. None of the reviewed treatments 
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1/0/0=1 No RCTs were found.  Comparisons between groups were only available in 4 of the 13 
included studies & for most studies only a pre-post comparison was available.  The 'best' 
results were found when inspecting the fourth planned meta-analysis which concerned 
generalised behaviour outside the Snoezelen in a pre-post comparison. This included 
seven studies & no heterogeneity was found. The effect size was large (0.76) & highly 
significant (p < .001), indicating that participants receiving Snoezelen developed more 
adaptive behaviour than they presented prior to the intervention.  Weaknesses in the 
examined research methodologies, the heterogeneity between research designs, the 
small number of available research projects, & the small number of participants in each 
research project, prevent a confirmation of this method as a valid therapeutic 



















4 reviews, 2 
guidelines) 
121 (1-45; 2) 
mainly single 
case design.  
Controls: 8 for  
1 study with 
matched 
control design  
0/0/0=0 The 34 articles include 4 reviews & 2 professional guidelines. Over the past 10 years 
research into behavioural interventions for SIB has yielded mixed results. These studies 
are primarily single case studies, & rarely include follow-up data. The efficacy of 
behavioural interventions for SIB was highly variable. For some people, when delivered 
in specialist settings, behavioural interventions can reduce the frequency with which they 
engage in SIB for the duration of the intervention. It is not possible to conclude as to the 
long term efficacy of these treatments, due to the lack of follow-up data. There is a 
dearth of research considering how these techniques may be applied in clinical or ‘real 
life’ settings, & despite a growing emphasis on positive behavioural support there has 
been little empirical evaluation of this in the treatment of SIB. 
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0/1/1=2 Most of the studies found a relationship between anxiety disorders/anxiety symptoms & 
CB. However, the associations between anxiety & CB must be interpreted within the 
context of associations found between other psychiatric disorders & CB. In three of the 
studies, anxiety had the strongest association with CB; in the other four studies, 
depression, bipolar disorder, psychosis or impulse control disorder had stronger 
associations with CB than anxiety. Two of the seven studies did not identify any 
statistically significant relationships between anxiety & CB, but they did notice signs of 
such relationships.  The study points toward the existence of a moderate association 
between anxiety & CB.  The relationship is complex in nature, probably bidirectional, & 
therefore no causal relationships can be inferred.  Further research is needed to clarify 












with data on 
prevalence 
16 ns 0/0/1=1 Of the 16 reviewed studies 10 utilized population-based sampling of which 6 were from 
one Scottish research team. Estimates of prevalence varied greatly & much of this 
variation was due to differences in the diagnostic criteria utilized & the specific samples 
examined.   Reported rates of diagnostic co-occurrence in population-based studies 
ranged from 14% to 74%. The high end of these rates was based upon psychiatric 
symptoms in a population sample of persons over 65 which do not equate to diagnosis.  
Consistently higher overall prevalence rate was found in studies that used administrative 
sampling, with estimates of prevalence of a mental disorder ranging from 29% to 75%.  It 
can be concluded with reasonable confidence that mental disorders & psychiatric 











reducing CB in 




















598; all SCSn.  
Controls: n/a 
all SCSn  
0/1/0=1  Quality rating for each study used in meta-analysis but not reported for each study.  
Overall intervention effect was high (-2.96) & statistically significant (Z =  13.16, p < 
.0001), suggesting that on average the interventions for CB in people with ID reported in 
the SCSn studies were highly effective.  In the final three level meta-analysis model, 
interventions on average were less effective for persons with aggression as CB-type, & 
more effective for persons with a diagnosis of ASD, for older participants, & where the 
intervention included the component 'Manipulating antecedent factors'.  After controlling 
for six extreme outliers, significant evidence was only found for the moderator effect of 
the CB topography aggression, & the intervention component manipulating antecedent 
factors. The overall effect of different contextual, behavioural, & pharmacological 
interventions for CB among persons with ID was large & statistically significant. 



















was evidence of publication bias (i.e. research reporting significant results more likely to 
be reported). Evidence was found endorsing the positive effects of psychotherapeutic 
and contextual intervention components, but no evidence for an overall positive effect of 
pharmacological interventions. The results of the multilevel meta-analysis of SCSn 
research to a large extent correspond with the conclusions of meta-analyses & reviews 






































0/1/1=2 Of the 50 studies, 17 were on prevalence, 28 associated factors, & 13 treatment. The 
results take into account levels of evidence.  Based on the most reliable studies, the 
prevalence of sleep problems in adults with ID ranges from 9% to 27% for settling 
problems, & from 11% to 34% for night waking problems. The prevalence of significant 
sleep problems is 9%.  Sleep problems were associated with the following factors: CB; 
respiratory disease; visual impairment; psychiatric conditions; & using psychotropic, 
antiepileptic and/or antidepressant medication.  There is no clear evidence for an 
association with age, gender or level of ID, conflicting evidence concerning the 
association of ASD & sleep problems, evidence of insufficient quality to confirm an 
association between dementia & sleep problems, no clear association with sleep 
problems & caffeine intake, evidence of an association with DS & sleep problems is 
conflicting. There is limited evidence of an association with communicative ability, living 
environment & grief.  There is some evidence that interventions (mainly based on 
behavioural/environmental improvement) are beneficial to treat sleep problems in adults 
with ID.  Research on the prevalence, associated factors & treatment of sleep problems 
in adults & older people with ID has mainly focused on subjectively derived data. The 
definitions used to describe a sleep problem are not uniform, & associations are mainly 
described as correlations. In order to give recommendations for clinical practice further 






























0/1/1=2 Most articles addressed the review topic as a secondary issue.  There were many 
categories about which no articles were found, e.g. menopause, cardiac & pulmonary 
disease, infectious disease & malignancies.  The review identified 11 well-conducted 
studies that found significant & independent associations with urinary incontinence, pain 
related to cerebral palsy & chronic sleep problems. Visual impairment was significantly 
associated with SIB.  No association was found with hearing impairment, bowel 
incontinence, mobility impairment or epilepsy. Twenty-one analytical studies of 
unsatisfactory quality & 13 non-analytical studies or case series, usually based on file 
data, suggest associations with gastroesophageal reflux disease (GORD), dysphagia, 
dementia, menstrual cycle phases &  specific sub-types of epilepsy. However, so far, 



















n=88 & 150 should be evaluated in the clinical setting.  Because of the cross-sectional design of all 
the studies, no firm conclusions can be drawn about the causative character of the 



















of ID of 100 












0/0/0=0 Of the 9 studies, 4 had a comparison group without ID and 5 had no comparison group. 
Studies with comparison group: 30% to 50% of children & adolescents with ID were 
identified as having a mental disorder compared with 8% to 18% of children &  
adolescents without ID. The relative risk of mental disorder associated with ID ranged 
from 2.8 to 4.5.  Studies without comparison group: reported prevalence estimates for 
mental disorder ranged from 30% to 41%.  The literature reviewed is limited with regard 
to the identification of risk factors associated with mental disorder among people with ID.  
Only three risk factors (age, gender, severity of ID) have been investigated with any 
degree of regularity, & results of these analyses are inconclusive. The results do suggest 
markedly increased rates of mental disorder among children & adolescents with ID.  
Appreciation of this comorbidity needs to be a fundamental component of both mental 
health & ID services 
Welch, 
Lawrie, 
















5 280 (25-104; 




0/0/0=0 The 5 studies compared a total of 280 individuals with schizophrenia & mild ID/borderline 
intellectual functioning (BIF) to 908 individuals with schizophrenia & average/high IQ.  
The mild ID/BIF group scored higher on scales measuring negative symptoms in four of 
the five studies reviewed, higher on scales measuring positive symptoms in two, & 
higher on scales measuring general symptoms in two.  Meta-analysis was only possible 
for negative symptoms (3 studies).  The meta-analysis of ratings on scales measuring 
negative symptoms produced an effect size of 1.72 (95% CI= 0.99-2.46). This is an 
extremely large effect size, indicating that ID individuals with schizophrenia experience 
substantially greater negative symptoms than patients with average/high IQ.  The 
available evidence supports the proposal that the clinical presentation of schizophrenia 


















n=6, 14 & 17.  
Controls: n=9, 
13 & 13. Not 
calculated for 
other studies 
due to wide 
variety of 
samples inc. 
0/0/0=0 Of the 25 studies, 3 were medication trials & one an open label continuation of one of 
the trials.  Review identified one study of a nonpharmacological intervention in adults 
with ID & dementia using structured psychotherapeutic groups for persons with ID & 
dementia.  Research & evidence for nonpharmacological therapeutic strategies for 
dementia in the ID population is rare.  The research evidence on antidementia drugs in 
people with ID is sparse at present & consists of small trials & case reports on side 
effects.  The evidence base of both nonpharmacological & pharmacological interventions 
that can help people with ID & dementia & their carers is insufficient because of the 
absence of systematic & robust studies.  Service organizations often have to extrapolate 
































persons with ID, 
















0/0/1=1 18 described a biological, 13 a psychotherapeutic & 9 a contextual intervention, with 
sometimes more than one implemented treatment discussed in a single article.  Effect 
sizes (standardised mean differences) ranged from 0.223 to 1.411 i.e. varying between a 
small & a very large effect, all indicating positive treatment effects. The combined effect 
size over all studies is 0.671 (95% CI= .570 - 0.771), which is a medium to large effect. 
The implemented sensitivity analysis revealed that this effect is robust. Analyses of 
variance showed no significantly different treatment effects for biological, 
psychotherapeutic & contextual interventions. Interventions for CB among persons with 
ID described in the 30 articles were effective, with only small differences between the 
mean effects for biological, psychotherapeutic & contextual treatments, & for unimodal & 





Overview of the 
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0/0/0=0 Assessment: no diagnostic instrument is available specifically aimed at assessing PTSD 
in ID. Caregivers often do not possess information concerning the person's trauma 
history or do not recognize events typically associated with PTSD. Certain events, for 
example a move arranged by others, is in general not considered as potentially 
traumatic but such events may have a negative or traumatizing effect on individuals with 
ID. Prevalence: 4 articles were found  reporting on incidence rates of PTSD in samples 
(with a total number of 359 persons) with ID who were referred for treatment, & had a 
history of one or more traumatic experiences.  Prevalence rates of PTSD varied 
substantially, from 3% to 60%; prevalence studies using large heterogeneous 
populations entirely lacking.  Treatment: 9 articles involve treatment of PTSD in people 
with ID. Interventions reported involve those aimed to establish environmental change, 
the use of medication & psychological treatments (i.e., CBT, Eye Movement 
Desensitization & Reprocessing (EMDR) & psychodynamic based treatments). Case 
reports suggest positive treatment effects for various treatment methods. Empirical 
studies of the pharmacological treatment of PTSD in people with ID are lacking.  
Development of diagnostic instruments for the assessment of PTSD & its 
symptomatology among people with ID is warranted, which could facilitate further 
research on prevalence.  Evidence based methods have to be developed to treat people 
with various levels of ID who suffer from PTSD. A first step might be to systematically 


















































0/0/0=0 Due to varied methodologies & challenges in diagnosis there is a wide range of reported 
prevalence, particularly in the results obtained from the small number of studies in adults 
with ID who do not have DS. Rates of dementia in the population with ID not because of 
DS are comparable with or higher than the general population. Alzheimer’s disease 
onset in DS appears earlier & the prevalence increases from under 10% in the 40s to 
more than 30% in the 50s, with varying prevalence reported for those 60 & older. 
Incidence rates increase with age. Few studies of dementia in other genetic syndromes 
were identified. Presentation differs in the ID population compared with the general 
population; those with DS present with prominent behavioural changes believed to be 
because of frontal lobe deficits.  In the future, larger studies with representative samples 
using comparable ascertainment & diagnostic methods, & a good description of 
















11 19 (1-6; 1); 14 
of these 




0/1/1=2 Assessment procedures included dental screening under sedation & interviews with 
caregivers. Intervention approaches included prosthodontics, dental surgery, injection of 
botulinum toxin-a, behaviour modification, music therapy, & contingent massage.   
Overall, 82% (n = 9) of the studies reported positive outcomes & 18% (n = 2) reported 
negative outcomes.  Overall, the evidence base is extremely limited & no definitive 
statements regarding treatment efficacy can be made.  None of the reviewed treatments 
would qualify as ‘well established’ evidence-based practice.   However, behaviour 
modification & dental or medical treatment options (e.g prosthodontics) seem to be 
promising treatment approaches. At present, a two-step assessment process, consisting 








disorder (PD) in 









ns ns 0/1/0=1 A previous review of diagnosis of PD in ID found reported prevalence rates from 1% to 
91% in community settings & 22% to 92% in hospital with previous authors concluding 
that no accurate prevalence figures for PD in ID are available.   However, there is a 
consensus that PD is more common in this population & that its distribution mirrors that 
found in the general population with significantly higher rates amongst inpatient 
psychiatric & prison populations.  In more recent studies, a prevalence of 22% was 
found amongst referrals to a specialist dual diagnosis service, & 39% of forensic ID 
clients had at least one PD.   No validated PD diagnostic scale exists for use in people 
with ID.   Assessment & diagnosis is complex & often overshadowed by ID. Few papers 
address treatment, there are no trial-based studies. The literature on PD in ID is notable 
for its paucity.  There is a lack of either research or guidance on the treatment or 
management of PD in this population & it has not been established if evidence on 
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7 119 in survey.  
Qualitative 
studies mixed 
samples of ID, 










0/1/1=2 Seven qualitative studies were identified, one of which also included a survey.  A range 
of stakeholder perspectives were reported (healthcare professionals, ID, parents, carers 
& supporters).   Six studies highlighted the issue of care provision, with significant 
emphasis on inadequate care (e.g. continent adults with ID being given continence pads, 
rather than taken to the toilet, people who needed special eating utensils not having 
access to them).  Communication was highlighted as a core issue in all but one of the 
articles, with people with ID frequently having difficulty communicating their needs.  In 
relation to staff attitudes, discrimination towards people with ID was noted to be 
'endemic'.  One study found a lack of knowledge among many nurses regarding the 
issue of ID.  Carers may chose to spend up to 24 hours a day at the hospital & their 
presence was valued by nurses.  In relation to the physical environment, simple 
strategies can promote safety, e.g. preadmission assessement, provision of symbols or 
pictures.  Six areas of influence on the health, safety & welfare of adults with ID in acute 
hospitals were identified: care provision (meeting health & personal needs); 
communication; staff attitudes; staff knowledge; supporters; & carers (valuing their role); 
physical environment.  These six areas are represented diagrammatically, as concentric 
rings. These influences on health, safety & welfare form an inner (direct) layer & an outer 
(indirect) layer consisting of liaison services & education/training. This conceptualisation 
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0/1/1=2 The nine studies included in the review offered a direct comparison among two or more 
ethnic groups in their level of mental health utilisation in people with ID. Six studies 
found a difference or an association between cultural & ethnic factors, & mental health 
utilisation. Differences found by these studies among ethnic groups ranged from small 
differences limited to a particular area to very significant & broad differences in 
psychiatric service use. Three studies found no statistically significant ethnic/cultural 
variation.  The most consistent finding was that South Asian children, adolescents & 
adults with ID in the UK had lower use of mental health services than White British 
comparison groups. The extent of ethnic variation in mental health service utilisation 
among people with ID in high income countries remains largely unexplored as this 
review only includes studies from two countries. 























care for people 
with ID 
2010 research frustrated. These factors include anxiety about going into hospital, long waiting times, 
lack of age-appropriate activities, feeling ignored by hospital staff, poor communication 
about investigations & treatments, fear of procedures & not having needs met.  People 
with ID & their carers perceived that staff tended to lack experience & knowledge of 
caring for people with ID. Staff had negative attitudes towards & were less confident in 
working with patients who had ID than those with physical disabilities.  Recurrent themes 
of difficulties in hospital emerged from the literature (e.g. confusing signage, given 
incontinence aids rather than being given assistance to get to a toilet, one person going 
without food because he was unable to open a packet of sandwiches).  Credible 
research in this area is lacking.  The review identified a variety of ways to improve the 
care people with ID receive in hospital (pre-admission visits, education & training for 
hospital staff, recognising & valuing the role of carers & meeting the needs of carers, 
improving the hospital environment & implementing the learning disability liaison role). 
Areas of good practice need to be evaluated & disseminated so that people with ID 





Impact of health 
checks for 







1,311; ns).  
Controls: ns. 
1/1/0=2 Of the 38 publications identified, three were based on RCTs.  The majority of studies 
were based on clinical interventions where a sample of people with ID received a single 
episode of a health check & information was presented on the outcome(s) of the health 
check.  Studies consistently suggest that health checks are effective in identifying a wide 
range of previously unidentified conditions, including serious & life-threatening conditions 
such as cancer, heart disease & dementia.  The evidence also suggests that health 
checks consistently lead to targeted actions to address health needs. However, few 
studies have investigated the extent to which the provision of health checks leads to 
short-, medium- or long-term changes in health status.  Overall, studies suggest that 
health checks are acceptable to the majority of people with ID & family carers who 
support them.  Health checks are effective in identifying previously unrecognised health 
needs, including life-threatening conditions. Future research should consider strategies 


















13 ns 0/0/0=0 People with ID experience a range of barriers to secondary health care & that their 
needs are not being adequately met when they go to hospital. The main barriers 
impacting on the experiences of people with ID & carers are related to the process of 
hospital care (for example, appointment systems & waiting times), the knowledge, 
attitudes & communicative style of health staff & the physical environment.  A range of 
recommendations & initiatives have been developed to improve hospital care.  More 
research is needed, given that so few studies are published in this area. Initiatives to 



































68 Not calculated 
due to high 
likelihood of 
double 
counting.  42 
of 68 studies 
had a sample 








0/0/0=0 Twenty-seven studies had a cross-sectional design with matched samples & 23 had a 
longitudinal design. In 18 studies investigators combined both & either compared 
‘movers’’ & ‘stayers’ or people moving to different types of residential arrangements.  
People in small scale community-based residences or in semi-independent or supported 
living arrangements had a better objective quality of life than did people in large, 
congregate settings. Particularly, they had more choice-making opportunities; larger 
social networks & more friends; accessed more mainstream activities & participated 
more in community life; had more chances to acquire new skills & develop or maintain 
existing skills; & were more satisfied with their living arrangements.  Five main 
conclusions emerge from this literature: the overall picture is comparable to previous 
reviews, namely, small-scale arrangements are superior to large, congregate options in 
most domains; there is considerable variability in individual outcomes based on 
individual & service characteristics; there are three areas where community-based 
services might not provide better outcomes (CB, psychotropic medication, & mortality); 
experiences are similar in different countries; & despite significant improvements, people 
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8 148 (10-50; 
15).   
Controls: 162 
(10-54; 23).  
Unknown for 
one study.    
1/1/1=3* Only interventions dealing with mental health problems of persons with ID were included, 
none focused on physical health problems. Three of the studies identified effective 
organisational interventions & five showed no evidence of effect.  By decreasing 
caseloads & increasing the frequency of direct care of participants in their natural 
environment one study found a significant increase in adaptive behaviour & a decrease 
in maladaptive behaviour in the intervention group; improvements in behaviour were 
found among control group participants who received bereavement counselling from 
bereavement counsellors with little experience working with people with ID; & services 
delivered by mainstream intensive case management teams with small case-loads 
significantly decreased the number of days in hospital for psychiatric reasons among 
persons with mild & borderline ID. Only two studies were similar enough to analyse using 
a meta-analysis. In the pooled analyses 25 participants received assertive community 
treatment & 25 received standard community treatment. Results from measures of 
function, caregiver burden & quality of life were non-significant.  There are currently no 
well designed studies focusing on organising the health services of persons with an ID & 
concurrent physical problems. There are a small number of studies of organisational 
interventions targeting mental health needs but the results of these require 
corroboration.  There is an urgent need for high quality health services research to 


















































groups of  
n=142 (ns for 
one study)   
0/1/0=1 Identified 10 quantitative studies, eight qualitative, one mixed methods, one with unclear 
methodology & two literature reviews.  One RCT was identified.  The main themes 
identified were: life experience, interaction between healthcare professionals & 
participants, ability to consent, & psychometric variables. A consensus seemed to 
emerge that capacity to consent is greater in people with higher cognitive ability & verbal 
skills, but that the attitudes & behaviour of healthcare professionals was also a crucial 
factor.  Some researchers investigated consent to research; others consent to treatment 
or (indirectly) consent to taking medication, while some used hypothetical vignettes & 
some ‘real life’ situations.  Limitations noted in applying finding of the studies to clinical 
practice.  The findings support use of the functional approach to assessing mental 
capacity for the purpose of obtaining informed consent.  The complexity & nature of the 
decision need to be taken into account. Whether or not capacity to consent is achieved 
may depend on the effort made to ‘tailor’ the relevant information to the abilities & needs 










adults (age 19 














2 500 (44 & 
456).  
Controls: 
n=44 & 458 
respectively. 
1/1/1=3* Only two studies identified, both compared personal assistance with usual care, one of 
which was randomised.  There was some evidence that personal assistance recipients 
may express greater satisfaction & fewer unmet needs than participants receiving other 
services. For physical health, though not a goal of the intervention, data suggest that 
that personal assistance had no comparative impact on mortality. Data on other health 
outcomes were mixed, with some trends in favour of personal assistance. There was no 
evidence of detrimental impacts. Further data would be required to draw conclusions 
about impacts on health & cost. This review did not find evidence that personal 
assistance reduces long-term institutional care. One trial found mixed effects on 
caregivers.  Personal assistance may have some benefits for some recipients, their 
friends & families; however, the relative total costs to recipients & society are unknown. 
This review does not indicate that personal assistance would be superior to other 
services for people who are already satisfied with the assistance they receive.  Further 




























1/1/1=3* This review identifies some evidence that personal assistance may benefit children with 
intellectual impairments. Impacts on carers appear somewhat mixed. Further data would 
be required to draw conclusions about cost.  Data suggest that that personal assistance 
had no comparative impact on mortality. Data on other health outcomes suggest 
personal assistance might have some beneficial impacts on health. There was no 
evidence of detrimental impacts.  No studies looked at the impact of personal assistance 
on mental health outcomes.  Research in this field is limited. While advocates may 



















impairments studies are required to determine which models of personal assistance are most 
effective & efficient for particular people. 
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percent body fat 
in individuals 




Any 11 219 (3-41; 
16).  Controls: 
94 (12-23; 15) 
0/1/1=2 Six studies used randomized control designs, the remainder pre-post quasi-experimental 
designs.  Ten studies used exercise training alone, one combined exercise & caloric 
restriction.  Aerobic training was incorporated into all interventions, & four studies also 
included a strength training component.  Three studies produced a loss of body fat 
amongst participants following an exercise training period. One study produced a 
significant increase in body fat following the intervention. Seven studies saw no change 
in body fat levels from pre to post tests.  The vast majority of studies reporting no 
change in outcome measures did not take into account the dietary intake or nutritional 
status of individuals with ID.  Methodological limitations make it difficult to evaluate 
effectiveness of reduction measures used to date.  The existing literature contains too 
few well-conducted studies to conclusively determine the efficacy of exercise training on 
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Interventions 
designed to 
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9 213 (1-79; 7).  
Controls:128 
(n=55 & 73)  
0/1/1=2 Review considers Feasibility, Appropriateness, Meaningfulness & Effectiveness (FAME) 
of tobacco and/or alcohol interventions. 4 papers focused on tobacco-related 
interventions, 3 on alcohol-related interventions & 2 on interventions designed to 
address both tobacco & alcohol.  There was one RCT, one quasi-experiment,3 case 
study approaches, 3 before & after studies, & one audit. No qualitative studies were 
identified.  Only two studies appeared to have appropriate theoretical underpinnings.  
Methodological limitations mean results should be treated with caution & little can be 
deduced regarding effectiveness.  Only one study (RCT) is informative in terms of 
effectiveness & this appeared to be effective in terms of raising the knowledge levels of 
people with ID in relation to tobacco & alcohol. However, there were methodological 
limitations that may impact on the validity of the results. There is a dearth of evidence & 
little to guide health & social care professionals.  There is an urgent need to develop 
theoretically driven tobacco & alcohol-related health promotion interventions & to ensure 
that the effectiveness of these interventions is tested in large-scale well designed trials.    
Li, Chen, 














0/1/1=2 Four fitness outcomes evaluated: balance, muscle strength & endurance, cardiovascular 
fitness, & body composition.  Exercise interventions led to moderate to high effects of 
improving muscular strength & balance (Cohen's d 0.74-1.10).  Other outcomes showed 
less conclusive or limited positive evidence.  There were no reported instances of injury 
sustained by any participants.  People with DS can benefit from physical exercise 
programs such as weight-bearing exercises, balance exercise, which show a trend of 
































Any to ns Any research 
design 
Total 11; of 




808; 261).  ID 
only studies 
2,341 (88-






0/1/1=2 In this review the term ‘disability’ is used to refer to any type of intellectual and/or 
developmental disability,  Six of the 11 studies included in the review reported 
statistically significant relationships between increased body mass index (BMI) in the 
children & parental/parenting factors (all included children with ID).  Socio-economic 
status, parents’ BMI, parents’ perception & attitude towards their children’s weight & 
level of physical activity, & actual levels of physical activity in parents & their children 
might be associated with overweight & obesity in children & adolescents with disability.  
However, findings were not consistent across studies. Firm conclusions remain elusive 
due to the small amount of research, the methodological limitations of the available 






















25 2,223 (1-361; 
68) approx 




groups.  Also 
2 group 
homes & 2 
support staff 
0/1/1=2 Nine papers reported using a pretest/posttest single group design, making this the most 
prevalent research design.  Seven used a pre/post control group design & three a 
pre/post comparative group design.  Other designs used were single group descriptive 
designs, process evaluations & one case study.   The majority of the included papers 
focused on exercise or healthy nutrition.  To improve the health of people with ID these 
topics are pertinent; however, there are several other key issues that must be addressed 
through health promotion including: healthy aging; osteoporosis, fractures & the 
prevention of falling incidents; constipation; mental health & well being, stress reduction 
& social well being.  Findings suggest that the field of health promotion research is 
underdeveloped for this group, with a need for theoretically driven studies. Given the 
health inequities they experience, it is critically important that public health & health 
promotion researchers ensure their study designs are inclusive of people with ID.   Only 
three studies used interventions adapted from general population interventions, 








& impact of self 
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of 10 or more 












(12-350; 38)  
approx.  2 
comparison 
0/1/1=2  Both ID & family carers experience stigma & it may have a negative impact on 
psychological wellbeing. Awareness of stigma in people with ID appears to be related to 
the extent to which individuals accept & internalise the label of ID. Most studies were 
qualitative or small descriptive studies. There is a lack of large prevalence studies & 





















of people with 
mental illness 
(n=66 & 108)  












14 ns 0/1/0=1 In a meta-analysis of the 14 studies, the overall effect size was 0.41, a small to medium 
effect.   The effect sizes of professional/scholastic measures (0.91) & exercise 
physiological data (0.84) were large, & the measures of performance were small (0.33), 
but the effect size of biometric & body composition data was trivial (0.03).  Short-duration 
exercise had a better effect than long-duration exercise, & the effect of exercising 4 
times per week was better than the effect of exercising 3 times per week (other 
frequencies were not reported). The most effective duration of exercise was 31–60 min, 
& exercise was more effective for older people than for younger people. Further studies 
must be performed with more specific outcome variables & moderating variables, such 
as age, exercise time, duration, frequency, & type of exercise program. A more 
comprehensive examination of moderating & mediating variables should be implemented 
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systematic 
review 




1/0/1=2 Nine studies were RCTs. One was a cohort-group study design, & the remaining study 
was a one-group pre–post-test design.  Reported results included: strength increases 
from baseline, ranging from 10% to 29%; a 4% decrease in heart rate after a walking test 
in intervention participants; balance improvements of between 9% & 25% for intervention 
groups compared with control groups; overall life satisfaction score increase of 4% for an 
intervention group compared with a 7% decrease for the control group; and an 
improvement in self-efficacy scores of 16% compared with a 4% improvement for the 
control group.  The authors report that there was strong evidence that physical activity 
positively affects balance & muscle strength in individuals with ID. There was moderate 
evidence that benefits in physical activity, function, & QOL could be experienced. 
Heller, 
McCubbin, 



























1/1/0=2 Of the 12 studies, 11 had a component related to exercise/physical activity, & 5 related 
to nutrition.  Some included both.  Only 3 of the 11 physical activity studies had a control 
or comparison group in the study design, limiting the validity of the findings in most of the 
studies.  The most common research design for the nutrition studies was a repeated 
measures design, without any comparison groups. Two used a randomized control 
group. Most of the studies included no longer term follow-up.  Outcomes of physical 
activity programs included improved fitness, weight reduction, fewer maladaptive 
behaviours & improved adaptive behaviours, better attitudes toward exercise, & 
improved life satisfaction.  Nutrition studies show some weight reduction for those who 



















with a more comprehensive health behaviour education program that incorporates 
exercise & nutrition information, stronger evidence exists for reductions in weight.  
Health promotion interventions incorporating physical activity, better nutrition, & health 
behaviour education can have some positive impacts on the health & function of adults 
with ID. However, the interventions need more rigorous testing because the evidence to 



























12 669 (1-201; 
23.5) includes 
control group 
for 1 study (ns 
separately).  
Also 1 study 
non-input 
group of 50, 1 
study group of 
97 non-ID  
0/1/0=1 Most frequent design was a quasi-experimental pretest & post-test design (9). Only one 
study had a clinical trial approach & there was one predominantly qualitative interview 
study.  Interventions included focus on nutrition, physical activity, health promotion 
including use of behavioural relapse prevention strategies, behavioural approaches 
concentrating on teaching self-control techniques & self-monitoring of food intake, a 
mindfulness programme, & educational programmes designed to increase 
understanding of the importance of maintaining a healthy lifestyle.  A number of studies 
reported a reduction in participants’ BMIs, & some identified the weight loss achieved as 
being statistically significant. Other positive outcomes reported included decreases in 
health risks, increased consumption of fruit & vegetables, & improvements in self-
reported exercise levels & cardiovascular fitness. Many of the studies reviewed are 
encouraging, but the general weakness of the evidence base is reflected in the quality 
assessment scoring & by the fact that only one study achieved a maximum score 
(scores are summarised and not available for individual studies).  There is a lack of 
















six years of age 







5. 77 (8-25; 16).  
Controls: 62 
(12-18; 16).  
139 (8-41; 
32).  Total of 
139 includes 
90 children 
with DS in 
three studies 
(n=22; 32; & 
36) 
1/1/1=3* Evidence suggested that treadmill intervention could lead to earlier onset of independent 
walking when compared to no treadmill intervention (two studies; effect estimate -1.47 
(95% CI= -2.97- 0.03)), though these trials studied two different populations & children 
with DS seemed to benefit while it was not clear if this was the case for children at high 
risk of neuromotor disabilities. Another two studies, both in children with DS, compared 
different types of treadmill intervention: one compared treadmill intervention with & 
without orthotics, while the other compared high versus low intensity treadmill 
intervention. Both were inconclusive regarding the impact of these different protocols on 
the age at which children started to walk.  The available evidence indicates that treadmill 
intervention may accelerate the development of independent walking in children with DS. 












3 56 (n=14, 16 
& 26) 
assumed 
1/1/1=3* In meta-analyses, only maximal treadmill grade was improved after aerobic exercise 
training programmes (4.26 grades (%) (95% CI= 2.06 - 6.45)). Other variables relative to 






























the intervention group: maximal test time (p=0.0003), total turns of fan wheel (p=0.02), 
resistance of ergometer (p=0.003), power knee extension & flexion (p<0.00001), & timed 
up & go test (p=0.008). Thirty other outcomes including, oxidative stress & body 
composition, could not be combined in the meta-analysis. Apart from work performance, 
trials reported no statistically significant improvements. There is insufficient evidence to 
demonstrate that aerobic exercise in adults with DS improves physical or psychosocial 
outcomes. Although evidence exists to support improvements in physiological & 
psychological aspects from strategies using mixed physical activity programmes, well-
conducted research examining long-term physical outcomes, adverse effects, 
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142 (8-31; 24) 
& 1 study non-
ID group of 
34.  Total 
sample for all 
studies noted 
to be 1,596 in 
article 
 
0/1/1=2 Twelve (52%) of the 23 studies recruited participants from Special Olympics (SO).  Of 8 
intervention studies, 2 were randomised trials.  Positive psychosocial outcomes of 
physical activity were reported, particularly with regard to self competence, self-esteem 
& self-concept. Several outcomes commonly reported in non-ID populations were 
missing in the studies retrieved in this review, including increased self-determination or 
empowerment & reduced depression & anxiety.  The improved physical fitness & 
elevated skill levels gained during exercise & sport activities were found to serve as 
mediators for increased perceptions of self-efficacy, as well as for personal & social 
competence. These factors, together with social support mechanisms, such as peer, 
attendant & family support, are important determinants of initiation & maintenance of 
physical activity. The specific contribution of segregated compared with integrated 
activity in this regard could not be ascertained.  Both exercise & sport-related activities 
seem to contribute to well-being. Improved physical fitness & elevated skill level gained 
during exercise & sport activities appear to serve as mediators for increased perceptions 
of self-efficacy & social competence. Peer modelling, as well as video & audio 






















1/1/1=3 The pooled prevalence of mobility limitations varied between 3% & 63% (excluding one 
study considered an outlier).  This variation can be partly explained by differences in the 
study populations & samples, including the prevalence of other disabilities, the 
distribution of age, gender or level of ID.   However, the biggest cause for variation 
among studies is likely related to measurement. Mobility limitations were loosely defined 
in studies & the measurement approach was rarely justified.  Studies addressing the 
epidemiology of mobility limitations in adults with ID, although reasonable in number, are 

































6 on DS 
from total of 
29; based 
on 2 RCTs   
45 in 2 RCTs 
by single lab, 
controls: 15 
0/1/1=2 Of 29 articles identified, 6 related to 2 RCTs involving infants with DS involving a total of 
60 infants with DS, 45 of whom participated in a treadmill intervention. One of the 2 
RCTs (level of evidence II) was the first to demonstrate that locomotor development, as 
measured by milestone achievement, in children with a known motor disability (DS) 
could be accelerated by as much as several months by practicing stepping on a treadmill 
while being supported by a parent for eight minutes per day. It also demonstrates the 
efficacy of treadmill training in children with a motor disability compared to a control 
intervention.  A second RCT evaluated whether development could be further 
accelerated by increasing intensity in terms of greater treatment time, speed & 
resistance.  The more intense group showed several beneficial short or longer term 
effects (up to 15 months after training ceased) including a more mature gait pattern as 
revealed through principal component analysis of multiple gait parameters, & through 
significant differences on several, but not all, measured temporal-spatial & kinematic gait 
parameters. The group that received more intense training also showed more advanced 
obstacle avoidance strategies & more time spent at moderate-high activity level at 15 
months post training, suggesting a possible longer term effect on levels of physical 
activity. Reports on adverse events consistently found that none of the possible risks 
that were anticipated & monitored were found to have occurred. Studies support the 
efficacy of treadmill training for promoting the development of independent walking & for 
advancing other quantitative & qualitative aspects of gait performance in DS. Some 
evidence suggests that a higher intensity of training may be more effective than a less 
intense protocol.  The intervention has not yet been compared to other possible methods 
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71 (a) 2,689 (8-
739; 118).  
Non-ID 
comparisons: 
n=40 & 49 







0/0/0=0 Tabulation & description of studies organised under headings: (a) dietary intake 
analysis, (b) anthropometric testing, (c) biochemical assessments, & (d) clinical 
examinations.  (a) current dietary intake methods are not adequate to gather valid food 
intake data in the population of adults with ID or DD living independently or semi-
independently.  Despite these data collection limitations, the trends indicate that adults 
with ID or DD who live in the community subsist on nutritionally poor diets planned & 
prepared by poorly trained support staff, are lacking guidance in making food selections, 
& have diets that may be inadequate in some essential nutrients & recommended food 
groups (e.g., fruits & vegetables & dairy) & excessive in other food groups (e.g., fats, 
sweets, & junk food).  (b) the population has a high proportion of overweight & 
underweight people outside the normal weight range.  (c) Lipid biochemistry testing had 
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150; 19).  
Controls: 370 









study   
factors present in adults with ID or DD. (d) Clinical assessments of adults with ID or DD 
have shown significant problems in the areas of CVD, bone health, gastrointestinal 
dysfunction, & eating difficulties. The prevalence of these clinical conditions has not 
been determined precisely. Significant nutrition-related risks exist for adults with ID or 
DD, including poor diet, elevated rates of over- & underweight, significant CVD risk 
factors, & multiple, limiting secondary conditions. 
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uptake in ID 
ns ns ns ns 0/0/0=0 Two large studies linked records of ID to cancer registries.  In Finland, no cervical cancer 
cases were observed in 1,693 women (30,042 person-years) when 2.9 expected.  In 
Australia, of 3,919 women (66,068 person-years), 2 cases were found where 5.68 were 
expected.  However, expected estimates are extremely unstable & should be treated 
with caution.  In conjunction with other smaller studies, this suggests that there is a lower 
incidence of cervical cancer in women with ID but some do get cervical cancer.  There 
are no known genetic conditions that enhance or decrease the risk of cervical cancer.  
Uptake of screening is low, with British studies suggesting rates between 7% & 28%.   
Whilst women with ID are at lower risk of cervical cancer, probably due to lower 
exposure to key risk factors such as human papilloma virus infection, there is a subgroup 
of women who are sexually active who should be actively recruited into screening 



























35 ns 1/0/0=1 Work on incidence of breast cancer in people with ID is limited & weakened by 
comparing different populations, aetiologies & data collection methods. Few studies 
specifically concentrate on breast cancer & those that have produce different 
conclusions about incidence.  Some studies suggest a low incidence in women with DS.  
The consensus from the literature was that up-take of breast cancer screening was lower 
in women with ID than women in the general population.  Barriers to uptake of screening 
include method of referral, physical disability, ID level, ill health of either women with ID 
or carers, moving area/into a nursing home, transport & fear of the procedure.  Three 
British studies have looked at improving uptake.  More research is needed into the 
incidence & prevalence of breast cancer & a better understanding of what knowledge, 
information & understanding, women with ID have & need in order to participate in breast 
screening. With increased risk factors such as nulliparity, limited exercise & obesity it is 
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1/1/1=3* In the majority of cases where antiepileptic drugs (AEDs) were trialled in this population, 
moderate reductions in seizure frequency & occasional seizure freedom were obtained.  
The quality of the studies does not aid clinicians greatly with respect to side effects. In 
general, in trial settings patients continued on treatment in the majority of cases, & 
placebo groups often experienced fewer side effects. Where side effects were 
experienced they appeared similar to those seen in non-ID studies. The majority of 
studies had a lack of or used non-reliable measures of behavioural exacerbation. Where 





















unblinded The review broadly supports the use of AEDs to reduce seizure frequency in people with 
refractory epilepsy & ID.  The evidence suggests that side effects are similar to those in 
the general population & that behavioural side effects leading to discontinuation are rare, 
but that other effects are under-researched.  It is not possible to comment on relative 






















8 1,362 (1-666; 
134) number 
of total with ID 





1/1/0=2 Six cohort studies & two case studies identified. Majority of participants were children or 
adolescents with only one cohort study & two case studies focusing on adults.  Where 
data was provided in the cohort studies between 32% & 38% of people with ID were 
diagnosed as not having epilepsy or as having non-epileptic events. The main reason for 
misdiagnosis was the misinterpretation of behavioural, physiological, syndrome related, 
medication related or psychological events by parents, paid carers & health 
professionals.  People may receive the incorrect treatment due to misdiagnosis e.g. if 
non-epileptic events are misdiagnosed as epileptic events people may be prescribed 
unnecessary antiepileptic medication.  There is a lack of research focusing on the 
diagnosis & misdiagnosis of epilepsy amongst people with ID. Families & those working 
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children with DS 
ns to 2008 Any study 
related to 
prevalence 
23 ns but noted 
that sample 
size ranged 
from 18 to 524 
0/0/0=0 The most common disorders affecting vision in children with DS were poor visual acuity 
(30% to 62%) & strabismus (3% to 57%). Hyperopia, found in 4% to 59% & astigmatism, 
found in 6% to 60% were also common.  Less common were myopia (8% to 41%), 
blepharitis (3% to 47%), & nystagmus (3% to 33%). Two studies found glaucoma 
affected more than 5% of patients. Early treatment of cataract can prevent amblyopia & 
this condition was found in more than 20% of patients by 2 studies.  Of the ocular 
findings not affecting vision, the most common were slanting fissures & epicanthic folds.  
The high prevalence of ophthalmic disorders in children with DS demonstrated by all 
studies highlights the need for these children to have ophthalmic assessment by a 
trained professional. A number of studies found conditions that are potentially 
detrimental to vision, such as cataract and glaucoma, in a significant minority of patients, 
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1/1/1=3 Of the 8 studies, 4 clearly used ID samples, 1 mixed ID/physically disabled, 1 
unspecified 'special needs', & 2 physically disabled.  For preventive programmes, quality 
of (all) studies was rated from level II to level III-3 with one RCT.  For restorative 
programmes, quality rated as level II to level III-2 with one RCT.  Due to heterogeneity, 
quality, number, types & outcomes of studies the review did not discover strategies for 
preventive & restorative care of caries in people with disabilities.  Clinical guidance could 
not be produced.  It was not possible to extract a common strategy for prevention & 
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0/1/1=2 People with ID are more likely to have poor oral hygiene & periodontal disease & 
possibly more likely to have caries than people without ID.  Levels of untreated caries 
were consistently higher in people with ID (% prevalence not given).  Elimination of this 
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1/1/1=3 Many studies focus on people with neurological disorders without mentioning whether 
they have ID. Most studies do not give exact definitions of the symptoms, making 
clustering of results difficult.  For example vomiting is defined as daily vomiting, including 
regurgitating; as persistent vomiting & regurgitation being two separate symptoms; or as 
repeated regurgitation (without mentioning vomiting as another symptom). There is no 
single symptom that is clearly related to GORD.  For example, vomiting was examined in 
eight studies. For five studies 2 × 2 tables could be reconstructed. Three of them 
revealed a significant difference in vomiting between the GORD & non-GORD group. 
Two studies did not find a statistically significant relationship between vomiting & the 
diagnosis of GORD. Sensitivity in the eight studies ranged from 22% to 100% (median 
57%). Vomiting in the non-GORD group was less frequent (5 studies, range 13%–31%, 
median 14%).  Vomiting, rumination & hematemesis are associated with a higher risk of 
the presence of GORD. There is no clear evidence that particular behavioural symptoms 
are indicative for GORD. Patients with cerebral palsy, patients using anticonvulsive 
drugs, & those with an IQ lower than 35 more frequently have GORD.  Nearly 50% of 
those with IQ < 50 have GORD.There is no single symptom that is clearly related to 
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994; 133).  
Controls: 225 
0/0/0=0 The majority of studies identified increased prevalence of osteoporosis & osteopenia 
with associated low bone mass density. In most studies individuals with ID presented 


























osteopenia in ID 
(23-108; 47) activity, early menopause in women, increased exposure to antiepileptics or 
antipsychotic medications).  Further research is needed to identify the prevalence of risk 
factors in people with ID.  Monitoring for risk factors associated with osteoporosis should 
be included in Health Action Plans & education regarding bone health offered to all the 







of morbidity & 

















0/1/0=1 Identified four epidemiological studies, two non-controlled trials, & one pilot study.  Up to 
57% of people with ID experienced a fall. Falling was the cause of 50–62% of all 
recorded injuries. Risk factors for falls in people with ID may include older age, impaired 
mobility, epilepsy & behavioural problems. There was a paucity of evidence for 
intervention strategies identified.  There is a lack of evidence for falls management in 
people with ID. Findings suggest that falls are a common cause of injury, 
institutionalisation & impaired quality of life in people with ID. Environmental safety, 
careful medical management & exercise interventions may play an important role in 
minimising fall-related injuries. Further research is needed to explore risk factors for falls 


























0/1/1=2 The 6 most prevalent chronic health conditions in children with ID were epilepsy 
(weighted mean prevalence 22.0/100; 95% CI=20.8–23.2), cerebral palsy (19.8/100; 
95% CI=18.6–21.1), any anxiety disorder (17.1/100; 95% CI=15.1–19.4), oppositional 
defiant disorder (12.4/100; 95% CI=10.7–14.4), DS (11.0/100; 95% CI= 10.5–11.4), & 
autistic disorder (10.1/100; 95% CI=8.8–11.6).  For visual problems, prevalence rates 
ranged from 2.2% to 26.8% (not possible to calculate weighted mean prevalence); 
hearing problems 0.0% to 7.1% (4.5/100; 95% CI=3.4–5.7).  Researchers in 7 studies 
reported prevalence rates of miscellaneous somatic chronic health conditions, such as 
chronic obstructive pulmonary disease (8.9%), gastric & esophageal diseases (6.9%), 
back & neck disorders (6.9%), osteoarthropathia (2.5%), cerebrovascular accident 
(range: 0.3% to 2.5%), Reye syndrome (0.3%), HIV (0.0%), & other chronic health 
conditions (4%). The weighted mean prevalence rate for cerebrovascular accident was 
2.0/100 (95% CI=1.8–2.3).  It was not possible to calculate a weighted mean prevalence 
rate for the other somatic chronic health conditions.  Prevalence rates of chronic health 
conditions in children with ID are higher than the prevalence rates reported in studies of 
children without ID.  However, the number of studies that were included & the number of 
chronic health conditions they reported about were limited.  
Haveman, 
Heller, Lee 






Any ns ns 0/0/0=0 The prevalence rates of health conditions for adults with ID were inconsistent among the 
studies. Only for some conditions (i.e., constipation) were the rates quite similar.  There 






















factors in aging 
persons with ID 
persons with ID in low- & middle-income countries.  Significant evidence is emerging that 
CVD is as prevalent among people with ID & is as common a cause of death as in the 
general population.  Digestive system problems were evident with high occurrence rates 
of helicobacter pylori, GORD, & constipation. The review revealed a growing body of 
work on health risk factors, such as overweight & obesity, which are often linked to the 
onset of a variety of diseases & impairing conditions. Healthier lifestyles, better nutrition 
& more exercise, & greater surveillance of health risks were seen as ways to improve the 
health status of aging adults with ID. 
Torr, 
Strydom, 
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25 tabulated DS: 2,794 (6-
420; 49).  
Comparison 
Groups Non 
DS ID: 5,040 
(8-1,178; 
141.5). Non-
ID: 3 studies 
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0/0/0=0 Findings are described by study in relation to psychiatric disorders, dementia of the 
Alzheimer type, pulmonary disorders, menopause, sensory impairments, & 
musculoskeletal disorders.  Dementia of the Alzheimer type among adults with DS is 
associated with high levels of morbidity. However, this overshadows very high rates of 
early onset age-related disorders, especially sensory impairments & musculoskeletal 
disorders. These are important disorders because of the associated functional disability, 
pain, & distress, as well as the increased risk of mortality associated with vision & 
mobility impairments. Functional decline in older adults with DS cannot be automatically 
assumed to be due to dementia of the Alzheimer type, which is not inevitable in all adults 
with DS. Functional decline may be the result from a range of disorders, especially 
sensory & musculoskeletal impairments. Given the high rates of early-onset age-related 
disorders among adults with DS, programmatic screening, monitoring, & preventive 
interventions are required to limit secondary disabilities & premature mortality. 
Acronyms: AAC: augmentative & alternative communication; AD: Alzheimer’s disease; ADHD: attention-deficit hyperactivity disorder; AED: antiepileptic drug; ASD: autistic spectrum disorder; BIF: 
borderline intellectual functioning; BMI: body mass index; CB: challenging behaviour; CBA: controlled before and after study; CBT: cognitive behavioural therapy; CPA: cyproterone acetate; CVD: 
cardiovascular disease; DD: developmental disabilities; DR: differential reinforcement; DS: Down’s syndrome; EBP: evidence-based practice; ECT: electroconvulsive therapy; EMDR: Eye Movement 
Desensitization & Reprocessing; FBA: functional behaviour assessment; FCT: functional communication training; FT + EXT: fixed time + extinction; FTST + EXT: fixed time + extinction with schedule 
thinning; GORD: gastroesophageal reflux disease; ID: intellectual disabilities; ITS: interrupted time series analysis; LHRH: luteinising hormone releasing hormone agonists; MBLR: mean baseline 
reduction; MO: motivating operations; MPA: medroxyprogesterone acetate; NAP: non-overlap of all pairs; NCR: non-contingent reinforcement; ns: not stated; PD: personality disorder; PECS: picture 
exchange communication system; PND: percentage of non-overlapping data; PTSD: post-traumatic stress disorder; QOL: quality of life; RCT: randomized controlled trial; SCSn : single-case & small-n;  
SIB: self-injurious behaviour; VT + EXT: variable time + extinction; VTST + EXT: variable time + extinction with schedule thinning 
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